NEWS: 公告在東京證券交易所JASDAQ標準市場新上市

表紙
市場調查報告書

抗病毒藥物市場(2021-2031):藥物類別、使用(肝炎、艾滋病毒、流感、皰疹等)、最終用戶、區域和主要國家市場分析、主要企業和 COVID-19 恢復情景預測

Antiviral Drugs Treatment Market Report 2021-2031: Forecasts by Drug Class, by Application (Hepatitis, HIV, Influenza, Herpes, Others), by End-user, Regional & Leading National Market Analysis, Leading Companies, and COVID-19 Recovery Scenarios

出版商 Visiongain Ltd 商品編碼 1013625
出版日期 內容資訊 英文 463 Pages
商品交期: 最快1-2個工作天內
價格
抗病毒藥物市場(2021-2031):藥物類別、使用(肝炎、艾滋病毒、流感、皰疹等)、最終用戶、區域和主要國家市場分析、主要企業和 COVID-19 恢復情景預測 Antiviral Drugs Treatment Market Report 2021-2031: Forecasts by Drug Class, by Application (Hepatitis, HIV, Influenza, Herpes, Others), by End-user, Regional & Leading National Market Analysis, Leading Companies, and COVID-19 Recovery Scenarios
出版日期: 2021年04月26日內容資訊: 英文 463 Pages
簡介

推動抗病毒藥物需求的主要因素是病毒性疾病的流行,包括艾滋病毒、流感、皰疹、肝炎和其他病毒。其他推動市場增長的增長因素包括人口老齡化的增加、抗病毒研發的進步、抗病毒市場戰略舉措的增加以及新興經濟體醫療基礎設施的發展。

此外,COVID-19 大流行對抗病毒藥物市場產生了重大影響,預計在預測期內對抗病毒藥物的需求將增加。

本報告探討了全球抗病毒藥物市場,到 2031 年的潛在收入來源、細分市場、定性分析、機會趨勢和抗病毒行業的業務。它提供了諸如主要公司的前景和概況等信息。

目錄

第 1 章報告概述

第 2 章執行摘要

第 3 章市場動態

  • 增長因素
    • 推動市場增長的病毒性疾病發病率增加
    • 老年人口增加促進抗病毒藥物需求
    • 抗病毒藥物研發進展帶來的市場增長
    • 抗病毒藥物市場不斷增加的戰略舉措是市場增長的另一個關鍵驅動力
  • 抑制因素
    • 與產品審批相關的嚴格規定阻礙了市場增長
    • 由於藥物開發成本高,對新進入者的限制
    • 對神經氨酸□抑製劑的總體耐藥性增加
  • 市場機會
    • 由於冠狀病毒感染增加,對抗病毒藥物的需求增加
    • 通過與主要供應商的合作併購提供市場增長機會
  • 波特五力分析
  • PEST 分析

第 4 章按藥物類別預測:抗病毒治療藥物市場 (2021-2031)

  • 逆轉錄□抑制劑細分市場預測(2021-2031)
    • 逆轉錄□抑制劑,一類主要用於治療 HIV 感染和乙型肝炎的抗逆轉錄病毒藥物
    • 逆轉錄□抑制劑的全球抗病毒藥物市場細分預測(2021-2031):復甦情景
  • 蛋白□抑制劑細分市場預測(2021-2031)
    • 抗逆轉錄病毒蛋白□抑制劑與 HIV 蛋白□的催化位點結合
    • 蛋白□抑制劑全球抗病毒藥物細分市場預測(2021-2031):復甦情景
  • DNA聚合□抑制劑細分市場預測(2021-2031)
    • DNA聚合□抑制劑是一種重要的治療策略,廣泛用於治療病毒感染
    • DNA 聚合□抑制劑的全球抗病毒藥物市場細分預測(2021-2031):復甦情景
  • 神經氨酸□轉錄□抑制劑細分市場預測(2021-2031)
    • 提高公眾對研發部門的認識和興趣,以支持新抗病毒藥物的開發
    • 神經氨酸□抑制劑全球抗病毒藥物市場細分預測(2021-2031):復甦情景
  • 其他細分市場預測(2021-2031)
    • 其他必需抑制劑
    • 其他細分市場的全球抗病毒藥物市場預測(2021-2031):復甦情景

第 5 章按使用情況預測:抗病毒治療藥物市場 (2021-2031)

  • 肝炎細分市場預測(2021-2031)
    • 丙型肝炎病毒 (HCV) 是收入增長最大的部分,它通過傳染性血液暴露和受 HCV 污染的血液和血液製品傳播。
    • 肝炎細分市場的全球抗病毒藥物市場預測(2021-2031):復甦情景
  • HIV 細分市場預測(2021-2031)
    • HIV 需要蛋白□進行複製(包括阿扎那韋、達蘆那韋、福沙那韋、洛匹那韋)
    • HIV 細分市場的全球抗病毒藥物市場預測(2021-2031):復甦情景
  • 流感抑制劑細分市場預測(2021-2031)
    • 抗病毒類神經氨酸□抑製劑(奧司他韋、扎那米韋、拉尼米韋、帕拉米韋)和 M2 蛋白抑製劑
    • 流感細分市場的全球抗病毒藥物市場預測(2021-2031 年):復甦情景
  • 皰疹細分市場預測(2021-2031)
    • 單純皰疹病毒 (HSV) 引起的皰疹發作。一種單純皰疹病毒,會在口腔和生殖器內和周圍形成瘡和水泡。
    • 皰疹細分市場全球抗病毒藥物市場預測(2021-2031):復甦情景
  • 其他細分市場預測(2021-2031)
    • 由於對先進藥物的需求增加,促進了細分市場的增長
    • 其他細分市場的全球抗病毒藥物市場預測(2021-2031):復甦情景

第 6 章最終用戶預測:抗病毒治療藥物市場 (2021-2031)

  • 醫院細分市場預測(2021-2031)
    • 大流行對抗病毒藥物的需求增加
    • 醫院部門的全球抗病毒藥物市場預測:復甦情景(2021-2031 年)
  • 臨床細分市場預測(2021-2031)
    • 增加抗病毒藥物用於乙型肝炎、皰疹病毒、流感病毒的一線治療
    • 臨床細分市場全球抗病毒藥物市場預測:復甦情景(2021-2031)
  • 其他細分市場預測(2021-2031)
    • 病毒感染領域研究機構的專業化
    • 恢復場景

第 7 章全球抗病毒藥物市場區域預測 (2021-2031)

  • 按地區劃分:全球抗病毒藥物市場預測(2021-2031)
  • 地區:全球抗病毒藥物市場預測:復甦情景

第 8 章北美抗病毒治療市場 (2021-2031)

  • 全球市場份額最大的北美
  • 國家/地區:北美抗病毒藥物市場預測(2021-2031)
  • 按藥物類別:北美抗病毒藥物市場預測
    • 按藥物類別:北美抗病毒藥物市場預測(2021-2031):復甦情景
  • 按應用:北美抗病毒藥物市場預測
    • 按應用:北美抗病毒藥物市場預測:復甦情景(2021-2031)
  • 最終用戶:北美抗病毒藥物市場預測
    • 最終用戶:北美抗病毒藥物市場預測(2021-2031):復甦情景
  • 美國抗病毒藥物市場預測(2021-2031)
    • 愛滋病毒、肝炎和冠狀病毒等病毒性疾病負擔加重
    • 先進的醫療保健基礎設施的存在
    • 美國抗病毒藥物市場預測(2021-2031):復甦情景
  • 加拿大抗病毒藥物市場預測(2021-2031)
    • 病毒性疾病和政府支持負擔加重
    • 在加拿大製造和研發運營的好處
    • 加拿大抗病毒藥物市場預測(2021-2031 年):復甦情景

第 9 章歐洲抗病毒治療市場 (2021-2031)

  • 全球人口老齡化對醫療保健系統的直接影響
  • 國家/地區:歐洲抗病毒藥物市場預測(2021-2031)
  • 按藥物類別:歐洲抗病毒藥物市場預測
    • 按藥物類別:歐洲抗病毒藥物市場預測(2021-2031):復甦情景
  • 按應用:歐洲抗病毒藥物市場預測
    • 按應用:歐洲抗病毒藥物市場預測:復甦情景(2021-2031)
  • 最終用戶:歐洲抗病毒藥物市場預測
    • 最終用戶:歐洲抗病毒藥物市場預測(2021-2031):復甦情景
  • 德國抗病毒藥物市場預測(2021-2031)
    • 強大的研發渠道和主要公司:增加產品發佈
    • 歐美甲型肝炎暴發
    • 德國抗病毒藥物市場預測(2021-2031):復甦情景
  • 英國抗病毒藥物市場預測(2021-2031)
    • 傳播 HIV 感染
    • 人口老齡化帶來的挑戰
    • 英國抗病毒藥物市場預測(2021-2031 年):復甦情景
  • 法國抗病毒藥物市場預測(2021-2031)
    • 老年人口增加
    • 具有勞動力靈活性的經濟型醫療保健服務
    • 法國抗病毒藥物市場預測(2021-2031):復甦情景
  • 意大利抗病毒藥物市場預測(2021-2031)
    • 不斷發展的製藥業
    • 意大利被評為世界長壽國家
    • 意大利抗病毒藥物市場預測(2021-2031):復甦情景
  • 西班牙抗病毒藥物市場預測(2021-2031)
    • 醫藥行業增長最強勁的經濟體
    • 在日本傳播 HIV
    • 西班牙抗病毒藥物市場預測(2021-2031):復甦情景
  • 俄羅斯抗病毒藥物市場預測(2021-2031)
    • 前景廣闊的俄羅斯製藥業
    • 未滿足的藥物需求
    • 俄羅斯抗病毒藥物市場預測(2021-2031):復甦情景
  • 其他歐洲抗病毒藥物市場預測(2021-2031)
    • 主要營銷商的病毒感染流行和戰略舉措
    • 其他歐洲抗病毒藥物市場預測(2021-2031):復甦情景

第 10 章亞太抗病毒治療市場 (2021-2031)

  • 增加對新興國家艾滋病毒的資助
  • 國家/地區:亞太抗病毒藥物市場預測(2021-2031)
  • 按藥物類別:亞太地區抗病毒藥物市場預測
    • 按藥物類別:亞太地區抗病毒藥物市場預測:復甦情景(2021-2031)
  • 按應用:亞太抗病毒藥物市場預測
    • 按應用:亞太抗病毒藥物市場預測:復甦情景(2021-2031)
  • 最終用戶:亞太地區抗病毒藥物市場預測
    • 最終用戶:亞太地區抗病毒藥物市場預測(2021-2031):復甦情景
  • 日本抗病毒藥物市場預測(2021-2031)
    • 日本在亞太地區擁有最大的市場份額
    • 政府倡議
    • 日本抗病毒藥物市場預測(2021-2031):復甦情景
  • 中國抗病毒藥物市場預測(2021-2031)
    • 市場公司採取的戰略舉措
    • 醫療保健費用增加
    • 中國抗病毒藥物市場預測(2021-2031):復甦情景
  • 印度抗病毒藥物市場預測(2021-2031)
    • 世界第三大艾滋病疫情在印度
    • 醫療基礎設施發展
    • 印度抗病毒藥物市場預測(2021-2031):復甦情景
  • 澳大利亞抗病毒藥物市場預測(2021-2031)
    • 政府計劃增加了獲得優質醫療保健的機會
    • 澳大利亞抗病毒藥物市場預測(2021-2031):復甦情景
  • 韓國抗病毒藥物市場預測(2021-2031)
    • HIV 在韓國的蔓延
    • 韓國抗病毒藥物市場預測:復甦情景(2021-2031)
  • 其他亞太抗病毒藥物市場預測(2021-2031)
    • 病毒感染正在該地區蔓延
    • 其他亞太抗病毒藥物市場預測(2021-2031):復甦情景

第 11 章拉丁美洲抗病毒治療市場 (2021-2031)

  • 增加老年人口和增加該地區的 GDP
  • 國家/地區:拉丁美洲抗病毒藥物市場預測(2021-2031)
  • 按藥物類別:拉丁美洲抗病毒藥物市場預測
    • 按藥物類別:拉丁美洲抗病毒藥物市場預測:復甦情景(2021-2031)
  • 按應用:拉丁美洲抗病毒藥物市場預測
    • 按應用:拉丁美洲抗病毒藥物市場預測:復甦情景(2021-2031)
  • 最終用戶:拉丁美洲抗病毒藥物市場預測
    • 最終用戶:拉丁美洲抗病毒藥物市場預測:復甦情景(2021-2031)
  • 巴西抗病毒藥物市場預測(2021-2031)
    • 巴西病毒性疾病負擔日益加重
    • 巴西抗病毒藥物市場預測(2021-2031):復甦情景
  • 墨西哥抗病毒藥物市場預測(2021-2031)
    • 墨西哥不斷發展的製藥業
    • 復甦情景:墨西哥抗病毒藥物市場預測(2021-2031)
  • 其他拉丁美洲抗病毒藥物市場預測(2021-2031)
    • 不斷發展的醫療保健基礎設施
    • 在該地區投資的政府和主要市場公司
    • 其他拉丁美洲抗病毒藥物市場預測(2021-2031):復甦情景

第 12 章中東和亞洲抗病毒藥物市場(2021-2031)

  • 國家/地區:中東和非洲抗病毒藥物市場,2021-2031 年預測
  • 按藥物類別對中東和非洲抗病毒藥物市場的預測
    • 按藥物類別劃分的中東/非洲抗病毒藥物市場預測:復甦情景(2021-2031)
  • 按應用:中東和非洲抗病毒藥物市場預測
    • 按應用:中東和非洲抗病毒藥物市場預測:復甦情景(2021-2031)
  • 最終用戶:中東和非洲抗病毒藥物市場預測
    • 最終用戶:中東和非洲抗病毒藥物市場預測:復甦情景(2021-2031)
  • 南非抗病毒藥物市場預測(2021-2031)
    • 南非新感染艾滋病毒排名第三
    • GDP 增長和傳染病管理取得重大進展
    • 南非抗病毒藥物市場預測:復甦情景(2021-2031)
  • 海灣合作委員會國家抗病毒藥物市場預測(2021-2031)
    • 本地區醫療保健行業的發展
    • 存在巨大的增長機會
    • GCC 國家抗病毒藥物市場預測:復甦情景:(2021-2031)
  • 其他中東/非洲抗病毒藥物市場預測(2021-2031)
    • 政府扶持醫藥產業發展
    • 其他中東和非洲其他抗病毒藥物市場預測:復甦情景(2021-2031)

第 13 章公司簡介

  • 公司股票分析
  • 抗病毒藥物市場的近期趨勢(2017-2020)
  • AbbVie Inc.
    • 公司快照
    • 公司簡介
    • 財務分析
    • 產品基準
    • 近期趨勢(2017-2020)
  • F. Hoffmann-La Roche Ltd
    • 公司快照
    • 公司簡介
    • 財務分析
    • 產品基準
    • 近期趨勢(2017-2020)
  • Gilead Sciences, Inc.
    • 公司快照
    • 公司簡介
    • 財務分析
    • 產品基準
    • 近期趨勢(2017-2020)
  • Boehringer
    • 公司快照
    • 公司簡介
    • 財務分析
    • 產品基準
    • 近期趨勢(2017-2020)
  • AstraZeneca
    • 公司快照
    • 公司簡介
    • 財務分析
    • 產品基準
    • 近期趨勢(2017-2020)
  • GlaxoSmithKline plc.
    • 公司快照
    • 公司簡介
    • 財務分析
    • 產品基準
    • 近期趨勢(2017-2020)
  • Novartis AG
    • 公司快照
    • 公司簡介
    • 財務分析
    • 產品基準
    • 近期趨勢(2017-2020)
  • Merck & Co., Inc.
    • 公司快照
    • 公司簡介
    • 財務分析
    • 產品基準
    • 近期趨勢(2017-2020)
  • Bristol-Myers Squibb Company
    • 公司快照
    • 公司簡介
    • 財務分析
    • 產品基準
    • 近期趨勢(2017-2020)
  • Johnson & Johnson Services, Inc.
    • 公司快照
    • 公司簡介
    • 財務分析
    • 產品基準
    • 近期趨勢(2017-2020)
  • Cipla Inc.
    • 公司快照
    • 公司簡介
    • 財務分析
    • 產品基準
    • 近期趨勢(2017-2020)
  • Abbott.
    • 公司快照
    • 公司簡介
    • 財務分析
    • 產品基準

第 14 章結論和建議

  • Visiongain 的結論
  • 給市場公司的建議
目錄
Product Code: PHA1051

Title:
Antiviral Drugs Treatment Market Report 2021-2031
Forecasts by Drug Class (Reverse Transcriptase Inhibitors, Protease Inhibitors, DNA Polymerase Inhibitors, Neuraminidase Inhibitors, Others), by Application (Hepatitis, HIV, Influenza, Herpes, Others), by End-user (Hospitals, Clinics, Others) AND Regional and Leading National Market Analysis PLUS Analysis of Leading Antiviral Drugs Companies AND COVID-19 Recovery Scenarios.

Antiviral Drugs Treatment Market - reveals latest trends, opportunities, predicted revenues, and competitive analysis. Read on to determine how you can exploit the impending business opportunities emerging in this sector along with detailed COVID-19 recovery scenarios.

Global antiviral drugs treatment market is projected to reach at a market value of US$xx billion by 2031 with a lucrative CAGR during the forecast period. The growing prevalence of viral diseases including HIV, influenza, herpes, hepatitis and other viral is a major factor that drives the demand for antiviral drugs treatment. Other key drivers boosting the market growth are increasing geriatric population; advancement in anti-viral drugs R&D; rising strategic initiatives for anti-viral drugs market and developing healthcare infrastructure in emerging economies. Additionally, the COVID-19 pandemic has a significant impact on the antiviral drugs treatment market. Thus, the demand for antiviral drugs treatment is expected to rise during the forecast period.

Visiongain's report shows you the potential revenues streams to 2031, assessing the different segments, major players, qualitative analysis, opportunities trends, and business prospects in the antiviral drugs treatment industry.

How this report will benefit you

Visiongain's new study is envisioned for anyone requiring commercial in-depth analyses for the global antiviral drugs treatment market along with detailed segment analysis in the market. Our new study assists you to evaluate the overall global and regional market for antiviral drugs treatment. Get the financial analysis of the overall market and different segments including by drug class, route of administration, usability, and distribution channel. High opportunity remains in this fast-growing antiviral drugs treatment market. See how to use the existing and upcoming opportunities in this market to gain revenue benefit in the near future. Moreover, the report would help you to improve your strategic decision making, allows you to frame growth strategies, reinforce the analysis of other market players, and maximise productivity of the company.

Forecasts to 2031 and other analyses reveal the commercial prospects

  • Our new study provides you with revenue forecast by different segments including drug class, application, and end user to 2031
  • It also includes growth rates for different 5 regional markets along with 18 countries and COVID-19 impact analysis on each market
  • The profiles of the top 12 companies are very descriptive and comprehensive data including company snapshot, overview, commercial developments, company market shares, and detailed financial analysis with revenue and other financials
  • The COVID-19 has a positive impact on the antiviral drugs treatment industry and the report includes detailed analysis and invaluable insight into how COVID-19 will affect the industry.

Discover sales forecasts for the global and regional market forecasts from 2021-2031

Along with revenue prediction for the overall global market, there is segmentation by region for 5 regional markets including North America, Europe, Asia Pacific, Latin America, and MEA and 20 major countries.

Global Antiviral Drugs Treatment Market Revenue and Growth Forecasts from 2021 to 2031 By Drug Class

  • Reverse Transcriptase Inhibitors
  • Protease Inhibitors
  • DNA Polymerase Inhibitors
  • Neuraminidase Inhibitors
  • Others

Global Antiviral Drugs Treatment Market Revenue and Growth Forecasts from 2021 to 2031 By Application

  • Hepatitis
  • HIV
  • Influenza
  • Herpes
  • Others

Global Antiviral Drugs Treatment Market Revenue and Growth Forecasts from 2021 to 2031 By End User

  • Hospitals
  • Clinics
  • Others

Regional market revenue and growth forecasts from 2021 to 2031:

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • UK
    • France
    • Italy
    • Spain
    • Russia
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • South Korea
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East and Africa
    • South Africa
    • GCC
    • Rest of MEA

Detailed profiles of 12 leading companies that are operating in the market

The report includes profiles of 12 major companies involved in the antiviral drugs treatment market. The companies profiled in this report include:

AbbVie, Cipla, Gilead Sciences, GlaxoSmithKline (GSK), Novartis, F. Hoffmann-La Roche Ltd, Boehringer Ingelheim Corporation, AstraZeneca AB, Johnson & Johnson, Merck & Co, Bristol-Myers-Squibb and Abbott Laboratories.

Find qualitative and quantitative analyses with independent predictions. Receive information that only our report contains, staying informed with this invaluable business intelligence.

In summary, our 460+ page report delivers you with the following knowledge:

  • Revenue forecasts from 2021 to 2031 for the global antiviral drugs treatment market and subsegments (by drug class, indication, distribution channel, and region)- discover the industry's prospects, finding the most lucrative areas for investments and revenue generation
  • Detailed profiles of top 12 antiviral drugs treatment manufacturers, with financial overviews for net revenues, operating income, R&D investment, and segment revenues
  • Revenue forecasts from 2021 to 2031 for 5 regional markets - See forecasts for the antiviral drugs treatment market in North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa.

Information found nowhere else

With this new and exclusive report, you are less likely to fall behind in knowledge or miss out on opportunities. See how our work could benefit your investment, research, analyses, and decisions. Visiongain's study is for everybody needing commercial analyses for the antiviral drugs treatment market and detailed analysis of COVID-19 impact. You will get the most recent data, opportunities, trends, and predictions.

The Antiviral Drugs Treatment Market Report 2021-2031 will be of value to anyone who wants to better understand the market and its various segments. It would be valuable for companies that desire to better understand the part of the industry they are involved in, or those coveting to expand or enter into a different regional market or to understand strategic analysis of leading companies of the antiviral drugs treatment industry.

Buy our report today“ Antiviral Drugs Treatment Market Report 2021-2031: Forecasts by Drug Class (Reverse Transcriptase Inhibitors, Protease Inhibitors, DNA Polymerase Inhibitors, Neuraminidase Inhibitors, Others), by Application (Hepatitis, HIV, Influenza, Herpes, Others), by End-user (Hospitals, Clinics, Others) AND Regional and Leading National Market Analysis PLUS Analysis of Leading Antiviral Drugs Companies AND COVID-19 Recovery Scenarios. ” Avoid missing out by staying informed - order our report now.

Visiongain is a trading partner with the US Federal Government.

Table of Contents

1. Report Overview

  • 1.1 Introduction to Antiviral Drugs Treatment Market
  • 1.2 Antiviral Drugs Treatment Market Definition
  • 1.3 Why You Should Read This Report
  • 1.4 What This Report Delivers
  • 1.5 Key Questions Answered By This Analytical Report Include:
  • 1.6 Who is This Report For?
  • 1.7 Methodology
    • 1.7.1 Primary Research
    • 1.7.2 Secondary Research
    • 1.7.3 Market Evaluation & Forecasting Methodology
  • 1.8 Frequently Asked Questions (FAQs)
  • 1.9 Associated Visiongain Reports
  • 1.10 About Visiongain

2 Executive Summary

3 Market Dynamics

  • 3.1 Drivers
    • 3.1.1 Increasing Incidence of Viral Diseases to drive market growth
    • 3.1.2 Increasing Geriatric Population is projected to propel the Demand for Anti-Viral Drugs
    • 3.1.3 Advancement in Anti-Viral Drugs R&D is driving the Market Growth
    • 3.1.4 Rising Strategic Initiatives for Anti-Viral Drugs Market is another Major Factor Propelling the Market Growth
  • 3.2 Restraints
    • 3.2.1 Stringent Regulations Associated with Product Approval Hinders the Market Growth
    • 3.2.2 High Costs of Drug Development Limits the Entry of New Players
    • 3.2.3 Rising Prevalent Resistance to Neuraminidase Inhibitors
  • 3.3 Opportunities
    • 3.3.1 Increasing Corona Virus Disease Emerge Need for Anti-Viral Drugs
    • 3.3.2 M&A and Collaboration by the leading Vendors Provide Opportunity to Grow in the Market
  • 3.4 Porter's Five Forces Analysis
    • 3.4.1 Bargaining Power of Supplier: Moderate
    • 3.4.2 Bargaining Power of Buyer: Moderate
    • 3.4.3 Competitive Rivalry: High
    • 3.4.4 Threat of New Entrants: Moderate
    • 3.4.5 Threat of Substitutes: Moderate
  • 3.5 PEST Analysis
    • 3.5.1 Political Factors Impacting Antiviral Drugs Treatment Market
    • 3.5.2 Economic Factors Impacting Anti-Viral Drugs Market
    • 3.5.3 Social Factors Impacting Anti-Viral Drugs Market
    • 3.5.4 Technological Factors Impacting Anti-Viral Drugs Market

4 Antiviral Drugs Treatment Market by Drug Class Forecast, 2021-2031

  • 4.1 Reverse Transcriptase Inhibitors Segment Market Forecast, 2021-2031
    • 4.1.1 The reverse-transcriptase inhibitors are class of antiretroviral drugs, majorly used to treat HIV infection and Hepatitis B
    • 4.1.2 Global Antiviral Drugs Treatment Market for Reverse Transcriptase Inhibitors Segment Forecast, 2021-2031: Recovery Scenarios (V, U, W, L)
  • 4.2 Protease Inhibitors Segment Market Forecast, 2021-2031
    • 4.2.1 The Antiretroviral protease inhibitors bind the catalytic site of the HIV protease
    • 4.2.2 Global Antiviral Drugs Treatment Market for Protease Inhibitors Segment Forecast, 2021-2031: Recovery Scenarios (V, U, W, L)
  • 4.3 DNA Polymerase Inhibitors Segment Market Forecast, 2021-2031
    • 4.3.1 Inhibiting DNA synthesis is significant therapeutic strategy, widely used to treat the viral infections
    • 4.3.2 Global Antiviral Drugs Treatment Market for DNA Polymerase Inhibitors Segment Forecast, 2021-2031: Recovery Scenarios (V, U, W, L)
  • 4.4 Neuraminidase Transcriptase Inhibitors Segment Market Forecast, 2021-2031
    • 4.4.1 Growing Public awareness, boost in the Research and Development segment swelling interest to support the development of new Antiviral drugs
    • 4.4.2 Global Antiviral Drugs Treatment Market for Neuraminidase Inhibitors Segment Forecast, 2021-2031: Recovery Scenarios (V, U, W, L)
  • 4.5 Others Segment Market Forecast, 2021-2031
    • 4.5.1 Other Essential Inhibitors
    • 4.5.2 Global Antiviral Drugs Treatment Market for Others Segment Forecast, 2021-2031: Recovery Scenarios (V, U, W, L)

5 Antiviral Drugs Treatment Market by Application Forecast, 2021-2031

  • 5.1 Hepatitis Segment Market Forecast, 2021-2031
    • 5.1.1 Largest Revenue Grossing Segment / Hepatitis C Virus (HCV) is transmitted through infective blood exposure, or by HCV contaminated blood and blood products
    • 5.1.2 Global Antiviral Drugs Treatment Market for Hepatitis Segment Forecast, 2021-2031: Recovery Scenarios (V, U, W, L)
  • 5.2 HIV Segment Market Forecast, 2021-2031
    • 5.2.1 HIV needs protease to replicate, which includes atazanavir, darunavir, fosamprenavir, and lopinavir
    • 5.2.2 Global Antiviral Drugs Treatment Market for HIV Segment Forecast, 2021-2031: Recovery Scenarios (V, U, W, L)
  • 5.3 Influenza Inhibitors Segment Market Forecast, 2021-2031
    • 5.3.1 The neuraminidase inhibitors (oseltamivir, zanamivir, laninamivir and peramivir) and M2 protein inhibitors are class of antiviral drugs to treat viral infection
    • 5.3.2 Global Antiviral Drugs Treatment Market for Influenza Segment Forecast, 2021-2031: Recovery Scenarios (V, U, W, L)
  • 5.4 Herpes Segment Market Forecast, 2021-2031
    • 5.4.1 Herpes is caused by Herpes simplex virus (HSV), which develops sores or blisters to form in or around the mouth or genitals
    • 5.4.2 Global Antiviral Drugs Treatment Market for Herpes Segment Forecast, 2021-2031: Recovery Scenarios (V, U, W, L)
  • 5.5 Others Segment Market Forecast, 2021-2031
    • 5.5.1 Growing Demand for Advanced Drugs Is Expected to Propel the Segment Growth
    • 5.5.2 Global Antiviral Drugs Treatment Market for Others Segment Forecast, 2021-2031: Recovery Scenarios (V, U, W, L)

6 Antiviral Drugs Treatment Market by End User Forecast, 2021-2031

  • 6.1 Hospital Segment Market Forecast, 2021-2031
    • 6.1.1 Pandemic emerge the demand for antiviral drugs
    • 6.1.2 Global Antiviral Drugs Treatment Market for Hospital Segment Forecast, 2021-2031: Recovery Scenarios (V, U, W, L)
  • 6.2 Clinics Segment Market Forecast, 2021-2031
    • 6.2.1 Increasing use of antiviral drugs for primary treatment include hepatitis B, herpes virus and Influenza virus
    • 6.2.2 Global Antiviral Drugs Treatment Market for Clinics Segment Forecast 2021-2031: Recovery Scenarios (V, U, W, L)
  • 6.3 Others Segment Market Forecast, 2021-2031
    • 6.3.1 The Research Institutes Specialize in the Field of Viral Infection
    • 6.3.2 Recovery Scenarios (V, U, W, L)

7 Global Antiviral Drugs Treatment Market Regional Forecast, 2021-2031

  • 7.1 Global Antiviral Drugs Treatment Market by Region Forecast 2021-2031
  • 7.2 Global Antiviral Drugs Treatment Market Forecast by Region: Recovery Scenarios (V, U, W, L)

8 North America Antiviral Drugs Treatment Market, 2021-2031

  • 8.1 Largest Market Share acquired by North America in Global Antiviral Drugs Treatment Market
  • 8.2 North America Antiviral Drugs Treatment Market by Country, Forecast 2021-2031
  • 8.3 North America Antiviral Drugs Treatment Market Forecast by Drug Class
    • 8.3.1 North America Antiviral Drugs Treatment Market Forecast by Drug Class, 2021-2031: Recovery Scenarios (V, U, W, L)
  • 8.4 North America Antiviral Drugs Treatment Market Forecast by Application
    • 8.4.1 North America Antiviral Drugs Treatment Market Forecast by Application, 2021-2031: Recovery Scenarios (V, U, W, L)
  • 8.5 North America Antiviral Drugs Treatment Market Forecast by End User
    • 8.5.1 North America Antiviral Drugs Treatment Market Forecast by End User, 2021-2031: Recovery Scenarios (V, U, W, L)
  • 8.6 U.S. Antiviral Drugs Treatment Market Forecast, 2021-2031
    • 8.6.1 Growing burden of Viral Diseases such as HIV, Hepatitis and Corona virus
    • 8.6.2 Presence of Highly Developed Healthcare Infrastructure
    • 8.6.3 U.S. Antiviral Drugs Treatment Market Forecast, 2021-2031: Recovery Scenarios (V, U, W, L)
  • 8.7 Canada Antiviral Drugs Treatment Market Forecast, 2021-2031
    • 8.7.1 Growing burden of Viral Diseases and Government support
    • 8.7.2 Benefits of manufacturing and R&D Operations in Canada
    • 8.7.3 Canada Antiviral Drugs Treatment Market Forecast, 2021-2031: Recovery Scenarios (V, U, W, L)

9 Europe Antiviral Drugs Treatment Market, 2021-2031

  • 9.1 Increasing aging population worldwide would have a direct impact on the healthcare systems,
  • 9.2 Europe Antiviral Drugs Treatment Market by Country, Forecast 2021-2031
  • 9.3 Europe Antiviral Drugs Treatment Market Forecast by Drug Class
    • 9.3.1 Europe Antiviral Drugs Treatment Market Forecast by Drug Class, 2021-2031: Recovery Scenarios (V, U, W, L)
  • 9.4 Europe Antiviral Drugs Treatment Market Forecast by Application
    • 9.4.1 Europe Antiviral Drugs Treatment Market Forecast by Application, 2021-2031: Recovery Scenarios (V, U, W, L)
  • 9.5 Europe Antiviral Drugs Treatment Market Forecast by End User
    • 9.5.1 Europe Antiviral Drugs Treatment Market Forecast by End User, 2021-2031: Recovery Scenarios (V, U, W, L)
  • 9.6 Germany Antiviral Drugs Treatment Market Forecast, 2021-2031
    • 9.6.1 Strong Research and Development pipelines coupled with increasing product launches by the major players
    • 9.6.2 Hepatitis A outbreaks in European Region and the Americas
    • 9.6.3 Germany Antiviral Drugs Treatment Market Forecast, 2021-2031: Recovery Scenarios (V, U, W, L)
  • 9.7 U.K. Antiviral Drugs Treatment Market Forecast, 2021-2031
    • 9.7.1 Growing HIV Infection
    • 9.7.2 Growing ageing population creating challenges
    • 9.7.3 U.K. Antiviral Drugs Treatment Market Forecast, 2021-2031: Recovery Scenarios (V, U, W, L)
  • 9.8 France Antiviral Drugs Treatment Market Forecast, 2021-2031
    • 9.8.1 Growing old age population
    • 9.8.2 Affordable Healthcare Services with Workforce Flexibility
    • 9.8.3 France Antiviral Drugs Treatment Market Forecast, 2021-2031: Recovery Scenarios (V, U, W, L)
  • 9.9 Italy Antiviral Drugs Treatment Market Forecast, 2021-2031
    • 9.9.1 Growing Pharmaceutical Industry
    • 9.9.2 Italy ranks amongst the countries with the maximum life expectancy worldwide
    • 9.9.3 Italy Antiviral Drugs Treatment Market Forecast, 2021-2031: Recovery Scenarios (V, U, W, L)
  • 9.10 Spain Antiviral Drugs Treatment Market Forecast, 2021-2031
    • 9.10.1 Strongest Economy with growing pharmaceutical Industry
    • 9.10.2 Spreading HIV in the country
    • 9.10.3 Spain Antiviral Drugs Treatment Market Forecast, 2021-2031: Recovery Scenarios (V, U, W, L)
  • 9.11 Russia Antiviral Drugs Treatment Market Forecast, 2021-2031
    • 9.11.1 Promising Russian Pharmaceutical Industry
    • 9.11.2 Unmet Pharmaceutical Needs
    • 9.11.3 Russia Antiviral Drugs Treatment Market Forecast, 2021-2031: Recovery Scenarios (V, U, W, L)
  • 9.12 Rest of Europe Antiviral Drugs Treatment Market Forecast, 2021-2031
    • 9.12.1 Growing prevalence of viral infections and strategic initiatives by major market players
    • 9.12.2 Rest of Europe Antiviral Drugs Treatment Market Forecast, 2021-2031: Recovery Scenarios (V, U, W, L)

10 Asia Pacific Antiviral Drugs Treatment Market, 2021-2031

  • 10.1 Increased funding for HIV in developing countries
  • 10.2 Asia Pacific Antiviral Drugs Treatment Market by Country, Forecast 2021-2031
  • 10.3 Asia Pacific Antiviral Drugs Treatment Market Forecast by Drug Class
    • 10.3.1 Asia Pacific Antiviral Drugs Treatment Market Forecast by Drug Class, 2021-2031: Recovery Scenarios (V, U, W, L)
  • 10.4 Asia Pacific Antiviral Drugs Treatment Market Forecast by Application
    • 10.4.1 Asia Pacific Antiviral Drugs Treatment Market Forecast by Application, 2021-2031: Recovery Scenarios (V, U, W, L)
  • 10.5 Asia Pacific Antiviral Drugs Treatment Market Forecast by End User
    • 10.5.1 Asia Pacific Antiviral Drugs Treatment Market Forecast by End User, 2021-2031: Recovery Scenarios (V, U, W, L)
  • 10.6 Japan Antiviral Drugs Treatment Market Forecast, 2021-2031
    • 10.6.1 Japan Accounted for the Largest Market Share in the Asia Pacific region
    • 10.6.2 Government Initiative
    • 10.6.3 Japan Antiviral Drugs Treatment Market Forecast, 2021-2031: Recovery Scenarios (V, U, W, L)
  • 10.7 China Antiviral Drugs Treatment Market Forecast, 2021-2031
    • 10.7.1 Strategic initiatives taken by market Player
    • 10.7.2 Increasing Healthcare Spending
    • 10.7.3 China Antiviral Drugs Treatment Market Forecast, 2021-2031: Recovery Scenarios (V, U, W, L)
  • 10.8 India Antiviral Drugs Treatment Market Forecast, 2021-2031
    • 10.8.1 India has the third largest HIV epidemic in the world
    • 10.8.2 Developing Healthcare Infrastructure
    • 10.8.3 India Antiviral Drugs Treatment Market Forecast, 2021-2031: Recovery Scenarios (V, U, W, L)
  • 10.9 Australia Antiviral Drugs Treatment Market Forecast, 2021-2031
    • 10.9.1 Government Programme Expand Access to Quality Healthcare
    • 10.9.2 Australia Antiviral Drugs Treatment Market Forecast, 2021-2031: Recovery Scenarios (V, U, W, L)
  • 10.10 South Korea Antiviral Drugs Treatment Market Forecast, 2021-2031
    • 10.10.1 Spreading HIV in South Korea Region
    • 10.10.2 South Korea Antiviral Drugs Treatment Market Forecast, 2021-2031: Recovery Scenarios (V, U, W, L)
  • 10.11 Rest of Asia Pacific Antiviral Drugs Treatment Market Forecast, 2021-2031
    • 10.11.1 Growing viral infection in this Region
    • 10.11.2 Rest of Asia Pacific Antiviral Drugs Treatment Market Forecast, 2021-2031: Recovery Scenarios (V, U, W, L)

11 Latin America Antiviral Drugs Treatment Market, 2021-2031

  • 11.1 Growing Geriatric population as well as growing GDP of this region
  • 11.2 Latin America Antiviral Drugs Treatment Market by Country, Forecast 2021-2031
  • 11.3 Latin America Antiviral Drugs Treatment Market Forecast by Drug Class
    • 11.3.1 Latin America Antiviral Drugs Treatment Market Forecast by Drug Class, 2021-2031: Recovery Scenarios (V, U, W, L)
  • 11.4 Latin America Antiviral Drugs Treatment Market Forecast by Application
    • 11.4.1 Latin America Antiviral Drugs Treatment Market Forecast by Application, 2021-2031: Recovery Scenarios (V, U, W, L)
  • 11.5 Latin America Antiviral Drugs Treatment Market Forecast by End User
    • 11.5.1 Latin America Antiviral Drugs Treatment Market Forecast by End User, 2021-2031: Recovery Scenarios (V, U, W, L)
  • 11.6 Brazil Antiviral Drugs Treatment Market Forecast, 2021-2031
    • 11.6.1 Growing burden of Viral Disease in Brazil
    • 11.6.2 Brazil Antiviral Drugs Treatment Market Forecast, 2021-2031: Recovery Scenarios (V, U, W, L)
  • 11.7 Mexico Antiviral Drugs Treatment Market Forecast, 2021-2031
    • 11.7.1 Growing Pharmaceutical Industry in Mexico
    • 11.7.2 Recovery Scenarios (V, U, W, L): Mexico Antiviral Drugs Treatment Market Forecast, 2021-2031
  • 11.8 Rest of Latin America Antiviral Drugs Treatment Market Forecast, 2021-2031
    • 11.8.1 Evolving Healthcare Infrastructure
    • 11.8.2 Government and Major market player investing in this region
    • 11.8.3 Rest of Latin America Antiviral Drugs Treatment Market Forecast, 2021-2031: Recovery Scenarios (V, U, W, L)

12 Middle East and Asia Antiviral Drugs Treatment Market, 2021-2031

  • 12.1 Middle East and Africa Antiviral Drugs Treatment Market by Country, Forecast 2021-2031
  • 12.2 Middle East and Africa Antiviral Drugs Treatment Market Forecast by Drug Class
    • 12.2.1 Middle East and Africa Antiviral Drugs Treatment Market Forecast by Drug Class, 2021-2031: Recovery Scenarios (V, U, W, L)
  • 12.3 Middle East and Africa Antiviral Drugs Treatment Market Forecast by Application
    • 12.3.1 Middle East and Africa Antiviral Drugs Treatment Market Forecast by Application, 2021-2031: Recovery Scenarios (V, U, W, L)
  • 12.4 Middle East and Africa Antiviral Drugs Treatment Market Forecast by End User
    • 12.4.1 Middle East and Africa Antiviral Drugs Treatment Market Forecast by End User, 2021-2031: Recovery Scenarios (V, U, W, L)
  • 12.5 South Africa Antiviral Drugs Treatment Market Forecast, 2021-2031
    • 12.5.1 South Africa ranks 3rd of all new HIV Infection in Southern Africa region
    • 12.5.2 Growing GDP and Substantial progress in the management of infectious diseases
    • 12.5.3 South Africa Antiviral Drugs Treatment Market Forecast, 2021-2031: Recovery Scenarios (V, U, W, L)
  • 12.6 GCC Antiviral Drugs Treatment Market Forecast, 2021-2031
    • 12.6.1 Developing Healthcare Industry in this region
    • 12.6.2 Presence of Huge Growth Opportunities
    • 12.6.3 GCC Antiviral Drugs Treatment Market Forecast, 2021-2031: Recovery Scenarios (V, U, W, L):
  • 12.7 Rest of Middle East and Asia Antiviral Drugs Treatment Market Forecast, 2021-2031
    • 12.7.1 Developing Pharmaceutical Industry along with government support
    • 12.7.2 Rest of Middle East and Africa Antiviral Drugs Treatment Market Forecast, 2021-2031: Recovery Scenarios (V, U, W, L)

13 Company Profiles

  • 13.1 Company Share Analysis
  • 13.2 Antiviral Drugs Market Recent Developments, 2017-2020
  • 13.3 AbbVie Inc.
    • 13.3.1 Company Snapshot
    • 13.3.2 Company Overview
    • 13.3.3 Financial Analysis
      • 13.3.3.1 Net Revenue, 2015-2019
      • 13.3.3.2 Product Revenue Shares, 2019
      • 13.3.3.3 Regional Revenue Shares, 2019
    • 13.3.4 Product Benchmarking
    • 13.3.5 Recent Developments, 2017-2020
  • 13.4 F. Hoffmann-La Roche Ltd
    • 13.4.1 Company Snapshot
    • 13.4.2 Company Overview
    • 13.4.3 Financial Analysis
      • 13.4.3.1 Net Revenue, 2015-2019
      • 13.4.3.2 Product Revenue Shares, 2019
      • 13.4.3.3 Regional Revenue Shares, 2019
    • 13.4.4 Product Benchmarking
    • 13.4.5 Recent Developments, 2017-2020
  • 13.5 Gilead Sciences, Inc.
    • 13.5.1 Company Snapshot
    • 13.5.2 Company Overview
    • 13.5.3 Financial Analysis
      • 13.5.3.1 Net Revenue, 2015-2019
      • 13.5.3.2 Product Revenue Shares, 2019
      • 13.5.3.3 Regional Revenue Shares, 2019
    • 13.5.4 Product Benchmarking
    • 13.5.5 Recent Developments, 2017-2020
  • 13.6 Boehringer Ingelheim International GmbH
    • 13.6.1 Company Snapshot
    • 13.6.2 Company Overview
    • 13.6.3 Financial Analysis
      • 13.6.3.1 Net Revenue, 2015-2019
      • 13.6.3.2 Product Revenue Shares, 2019
      • 13.6.3.3 Regional Revenue Shares, 2019
    • 13.6.4 Product Benchmarking
    • 13.6.5 Recent Developments, 2017-2020
  • 13.7 AstraZeneca
    • 13.7.1 Company Snapshot
    • 13.7.2 Company Overview
    • 13.7.3 Financial Analysis
      • 13.7.3.1 Net Revenue, 2015-2019
      • 13.7.3.2 Product Revenue Shares, 2019
      • 13.7.3.3 Regional Revenue Shares, 2019
    • 13.7.4 Product Benchmarking
    • 13.7.5 Recent Developments, 2017-2020
  • 13.8 GlaxoSmithKline plc.
    • 13.8.1 Company Snapshot
    • 13.8.2 Company Overview
    • 13.8.3 Financial Analysis
      • 13.8.3.1 Net Revenue, 2015-2019
      • 13.8.3.2 Product Revenue Shares, 2019
      • 13.8.3.3 Regional Revenue Shares, 2019
    • 13.8.4 Product Benchmarking
    • 13.8.5 Recent Developments, 2017-2020
  • 13.9 Novartis AG
    • 13.9.1 Company Snapshot
    • 13.9.2 Company Overview
    • 13.9.3 Financial Analysis
      • 13.9.3.1 Net Revenue, 2015-2019
      • 13.9.3.2 Product Revenue Shares, 2019
      • 13.9.3.3 Regional Revenue Shares, 2019
    • 13.9.4 Product Benchmarking
    • 13.9.5 Recent Developments, 2017-2020
  • 13.10 Merck & Co., Inc.
    • 13.10.1 Company Snapshot
    • 13.10.2 Company Overview
    • 13.10.3 Financial Analysis
      • 13.10.3.1 Net Revenue, 2015-2019
      • 13.10.3.2 Product Revenue Shares, 2019
      • 13.10.3.3 Regional Revenue Shares, 2019
    • 13.10.4 Product Benchmarking
    • 13.10.5 Recent Developments, 2017-2020
  • 13.11 Bristol-Myers Squibb Company
    • 13.11.1 Company Snapshot
    • 13.11.2 Company Overview
    • 13.11.3 Financial Analysis
      • 13.11.3.1 Net Revenue, 2015-2019
      • 13.11.3.2 Regional Revenue Shares, 2019
    • 13.11.4 Product Benchmarking
    • 13.11.5 Recent Developments, 2017-2020
  • 13.12 Johnson & Johnson Services, Inc.
    • 13.12.1 Company Snapshot
    • 13.12.2 Company Overview
    • 13.12.3 Financial Analysis
      • 13.12.3.1 Net Revenue, 2015-2019
      • 13.12.3.2 Product Revenue Shares, 2019
      • 13.12.3.3 Regional Revenue Shares, 2019
    • 13.12.4 Product Benchmarking
    • 13.12.5 Recent Developments, 2017-2020
  • 13.13 Cipla Inc.
    • 13.13.1 Company Snapshot
    • 13.13.2 Company Overview
    • 13.13.3 Financial Analysis
      • 13.13.3.1 Net Revenue, 2015-2019
      • 13.13.3.2 Regional Revenue Shares, 2019
    • 13.13.4 Product Benchmarking
    • 13.13.5 Recent Developments, 2017-2020
  • 13.14 Abbott.
    • 13.14.1 Company Snapshot
    • 13.14.2 Company Overview
    • 13.14.3 Financial Analysis
      • 13.14.3.1 Net Revenue, 2015-2019
      • 13.14.3.2 Product Revenue Shares, 2019
      • 13.14.3.3 Regional Revenue Shares, 2019
    • 13.14.4 Product Benchmarking

14 Conclusion and Recommendations

  • 14.1 Concluding Remarks from Visiongain
  • 14.2 Recommendations for Market Players

List of Tables

  • Table 1 Global Antiviral Drugs Treatment Market Snapshot, 2021 & 2031 (US$ billion, CAGR %)
  • Table 2 Global Antiviral Drugs Treatment Market Forecast by Drug Class, 2021-2031 (US$ bn, AGR%, CAGR%)
  • Table 3 Commonly used DNA Polymerase Inhibitors
  • Table 4 Global Antiviral Drugs Treatment Market for Reverse Transcriptase Inhibitors Segment Forecast, 2021-2031 (US$ bn, AGR%, CAGR%)
  • Table 5 Global Antiviral Drugs Treatment Market for Reverse Transcriptase Inhibitors Segment Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
  • Table 6 Global Antiviral Drugs Treatment Market for Reverse Transcriptase Inhibitors Segment Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
  • Table 7 Global Antiviral Drugs Treatment Market for Reverse Transcriptase Inhibitors Segment Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
  • Table 8 Global Antiviral Drugs Treatment Market for Reverse Transcriptase Inhibitor Segment Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
  • Table 9 Global Antiviral Drugs Treatment Market for Protease Inhibitors Segment Forecast, 2021-2031 (US$ bn, AGR%, CAGR%)
  • Table 10 Global Antiviral Drugs Treatment Market for Protease Inhibitors Segment Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
  • Table 11 Global Antiviral Drugs Treatment Market for Protease Inhibitors Segment Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
  • Table 12 Global Antiviral Drugs Treatment Market for Protease Inhibitors Segment Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
  • Table 13 Global Antiviral Drugs Treatment Market for Protease Inhibitor Segment Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
  • Table 14 Commonly used DNA Polymerase Inhibitors
  • Table 15 Global Antiviral Drugs Treatment Market for DNA Polymerase Inhibitors Segment Forecast, 2021-2031 (US$ bn, AGR%, CAGR%)
  • Table 16 Global Antiviral Drugs Treatment Market for DNA Polymerase Inhibitors Segment Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
  • Table 17 Global Antiviral Drugs Treatment Market for DNA Polymerase Inhibitors Segment Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
  • Table 18 Global Antiviral Drugs Treatment Market for DNA Polymerase Inhibitors Segment Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
  • Table 19 Global Antiviral Drugs Treatment Market for DNA Polymerase Inhibitor Segment Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
  • Table 20 Commonly used Neuraminidase Inhibitor's
  • Table 21 Global Antiviral Drugs Treatment Market for Neuraminidase Transcriptase Inhibitors Segment Forecast, 2021-2031 (US$ bn, AGR%, CAGR%)
  • Table 22 Global Antiviral Drugs Treatment Market for Neuraminidase Inhibitors Segment Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
  • Table 23 Global Antiviral Drugs Treatment Market for Neuraminidase Inhibitors Segment Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
  • Table 24 Global Antiviral Drugs Treatment Market for Neuraminidase Inhibitors Segment Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
  • Table 25 Global Antiviral Drugs Treatment Market for Neuraminidase Inhibitor Segment Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
  • Table 26 Global Antiviral Drugs Treatment Market for Others Segment Forecast, 2021-2031 (US$ bn, AGR%, CAGR %)
  • Table 27 Global Antiviral Drugs Treatment Market for Others Segment Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
  • Table 28 Global Antiviral Drugs Treatment Market for Others Segment Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
  • Table 29 Global Antiviral Drugs Treatment Market for Others Segment Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
  • Table 30 Global Antiviral Drugs Treatment Market for Others Segment Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
  • Table 31 Global Antiviral Drugs Treatment Market Forecast by Application, 2021-2031 (US$ bn, AGR%, CAGR%)
  • Table 32 Global Antiviral Drugs Treatment Market for Hepatitis Segment Forecast, 2021-2031 (US$ bn, AGR%, CAGR%)
  • Table 33 Global Antiviral Drugs Treatment Market for Hepatitis Segment Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
  • Table 34 Global Antiviral Drugs Treatment Market for Hepatitis Segment Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
  • Table 35 Global Antiviral Drugs Treatment Market for Hepatitis Segment Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
  • Table 36 Global Antiviral Drugs Treatment Market for Hepatitis Segment Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
  • Table 37 Global Antiviral Drugs Treatment Market for HIV Segment Forecast, 2021-2031 (US$ bn, AGR%, CAGR%)
  • Table 38 Global Antiviral Drugs Treatment Market for HIV Segment Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
  • Table 39 Global Antiviral Drugs Treatment Market for HIV Segment Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
  • Table 40 Global Antiviral Drugs Treatment Market for HIV Segment Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
  • Table 41 Global Antiviral Drugs Treatment Market for HIV Segment Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
  • Table 42 Global Antiviral Drugs Treatment Market for Influenza Segment Forecast, 2021-2031 (US$ bn, AGR%, CAGR%)
  • Table 43 Global Antiviral Drugs Treatment Market for Influenza Segment Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
  • Table 44 Global Antiviral Drugs Treatment Market for Influenza Segment Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
  • Table 45 Global Antiviral Drugs Treatment Market for Influenza Segment Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
  • Table 46 Global Antiviral Drugs Treatment Market for Influenza Segment Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
  • Table 47 Global Antiviral Drugs Treatment Market for Herpes Segment Forecast, 2021-2031 (US$ bn, AGR%, CAGR%)
  • Table 48 Global Antiviral Drugs Treatment Market for Herpes Segment Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
  • Table 49 Global Antiviral Drugs Treatment Market for Herpes Segment Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
  • Table 50 Global Antiviral Drugs Treatment Market for Herpes Segment Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
  • Table 51 Global Antiviral Drugs Treatment Market for Herpes Segment Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
  • Table 52 Global Antiviral Drugs Treatment Market for Others Segment Forecast, 2021-2031 (US$ bn, AGR%, CAGR%)
  • Table 53 Global Antiviral Drugs Treatment Market for Others Segment Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
  • Table 54 Global Antiviral Drugs Treatment Market for Others Segment Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
  • Table 55 Global Antiviral Drugs Treatment Market for Others Segment Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
  • Table 56 Global Antiviral Drugs Treatment Market for Others Segment Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
  • Table 57 Global Antiviral Drugs Treatment Market Forecast by End User, 2021-2031 (US$ bn, AGR%, CAGR%)
  • Table 58 Global Antiviral Drugs Treatment Market for Hospital Segment Forecast, 2021-2031 (US$ bn, AGR%, CAGR%)
  • Table 59 Global Antiviral Drugs Treatment Market for Hospital Segment Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
  • Table 60 Global Antiviral Drugs Treatment Market for Hospital Segment Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
  • Table 61 Global Antiviral Drugs Treatment Market for Hospital Segment Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
  • Table 62 Global Antiviral Drugs Treatment Market for Hospital Segment Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
  • Table 63 Global Antiviral Drugs Treatment Market for Clinics Segment Forecast, 2021-2031 (US$ bn, AGR%, CAGR%)
  • Table 64 Global Antiviral Drugs Treatment Market for Clinics Segment Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
  • Table 65 Global Antiviral Drugs Treatment Market for Clinics Segment Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
  • Table 66 Global Antiviral Drugs Treatment Market for Clinics Segment Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
  • Table 67 Global Antiviral Drugs Treatment Market for Clinics Segment Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
  • Table 68 Global Antiviral Drugs Treatment Market for Others Segment Forecast, 2021-2031 (US$ bn, AGR%, CAGR%)
  • Table 69 Global Antiviral Drugs Treatment Market for Others Inhibitors Segment Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
  • Table 70 Global Antiviral Drugs Treatment Market for Others Segment Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
  • Table 71 Global Antiviral Drugs Treatment Market for Others Segment Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
  • Table 72 Global Antiviral Drugs Treatment Market for Others Segment Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
  • Table 73 Global Antiviral Drugs Treatment Market Forecast by Region, 2021-2031 (US$ bn, AGR%, CAGR%)
  • Table 74 Global Antiviral Drugs Treatment Market Forecast by Region, 2021-2031 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
  • Table 75 Global Antiviral Drugs Treatment Market Forecast by Region, 2021-2031 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
  • Table 76 Global Antiviral Drugs Treatment Market Forecast by Region, 2021-2031 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
  • Table 77 Global Antiviral Drugs Treatment Market Forecast by Region, 2021-2031 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
  • Table 78 North America Antiviral Drugs Treatment Market Forecast by Country, 2021-2031 (US$ bn, AGR%, CAGR%)
  • Table 79 North America Antiviral Drugs Treatment Market Forecast by Drug Class, 2021-2031 (US$ bn, AGR%, CAGR%)
  • Table 80 North America Antiviral Drugs Treatment Market Forecast by Drug Class, 2021-2031 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
  • Table 81 North America Antiviral Drugs Treatment Market Forecast by Drug Class, 2021-2031 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
  • Table 82 North America Antiviral Drugs Treatment Market Forecast by Drug Class, 2021-2031 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
  • Table 83 North America Antiviral Drugs Treatment Market Forecast by Drug Class, 2021-2031 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
  • Table 84 North America Antiviral Drugs Treatment Market Forecast by Application, 2021-2031 (US$ bn, AGR%, CAGR%)
  • Table 85 North America Antiviral Drugs Treatment Market Forecast by Application, 2021-2031 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
  • Table 86 North America Antiviral Drugs Treatment Market Forecast by Application, 2021-2031 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
  • Table 87 North America Antiviral Drugs Treatment Market Forecast by Application, 2021-2031 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
  • Table 88 North America Antiviral Drugs Treatment Market Forecast by Drug Class, 2021-2031 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
  • Table 89 North America Antiviral Drugs Treatment Market Forecast by End User, 2021-2031 (US$ bn, AGR%, CAGR%)
  • Table 90 North America Antiviral Drugs Treatment Market Forecast by End User, 2021-2031 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
  • Table 91 North America Antiviral Drugs Treatment Market Forecast by End User, 2021-2031 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
  • Table 92 North America Antiviral Drugs Treatment Market Forecast by End User, 2021-2031 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
  • Table 93 North America Antiviral Drugs Treatment Market Forecast by End User, 2021-2031 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
  • Table 94 U.S. Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%)
  • Table 95 U.S. Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
  • Table 96 U.S. Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
  • Table 97 U.S. Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
  • Table 98 U.S. Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
  • Table 99 Canada Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%)
  • Table 100 Canada Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
  • Table 101 Canada Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
  • Table 102 Canada Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
  • Table 103 Canada Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
  • Table 104 Europe Antiviral Drugs Treatment Market Forecast by Country, 2021-2031 (US$ bn, AGR%, CAGR%)
  • Table 105 Europe Antiviral Drugs Treatment Market Forecast by Drug Class, 2021-2031 (US$ bn, AGR%, CAGR%)
  • Table 106 Europe Antiviral Drugs Treatment Market Forecast by Drug Class, 2021-2031 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
  • Table 107 Europe Antiviral Drugs Treatment Market Forecast by Drug Class, 2021-2031 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
  • Table 108 Europe Antiviral Drugs Treatment Market Forecast by Drug Class, 2021-2031 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
  • Table 109 Europe Antiviral Drugs Treatment Market Forecast by Drug Class, 2021-2031 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
  • Table 110 Europe Antiviral Drugs Treatment Market Forecast by Application, 2021-2031 (US$ bn, AGR%, CAGR%)
  • Table 111 Europe Antiviral Drugs Treatment Market Forecast by Application, 2021-2031 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
  • Table 112 Europe Antiviral Drugs Treatment Market Forecast by Application, 2021-2031 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
  • Table 113 Europe Antiviral Drugs Treatment Market Forecast by Application, 2021-2031 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
  • Table 114 Europe Antiviral Drugs Treatment Market Forecast by Drug Class, 2021-2031 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
  • Table 115 Europe Antiviral Drugs Treatment Market Forecast by End User, 2021-2031 (US$ bn, AGR%, CAGR%)
  • Table 116 Europe Antiviral Drugs Treatment Market Forecast by End User, 2021-2031 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
  • Table 117 Europe Antiviral Drugs Treatment Market Forecast by End User, 2021-2031 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
  • Table 118 Europe Antiviral Drugs Treatment Market Forecast by End User, 2021-2031 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
  • Table 119 Europe Antiviral Drugs Treatment Market Forecast by End User, 2021-2031 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
  • Table 120 Germany Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR %)
  • Table 121 Germany Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
  • Table 122 Germany Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
  • Table 123 Germany Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
  • Table 124 Germany Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
  • Table 125 U.K. Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%)
  • Table 126 U.K. Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
  • Table 127 U.K. Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
  • Table 128 U.K. Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
  • Table 129 U.K. Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
  • Table 130 France Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%)
  • Table 131 France Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
  • Table 132 France Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
  • Table 133 France Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
  • Table 134 France Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
  • Table 135 Italy Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%)
  • Table 136 Italy Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
  • Table 137 Italy Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
  • Table 138 Italy Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
  • Table 139 Italy Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
  • Table 140 Spain Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%)
  • Table 141 Spain Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
  • Table 142 Spain Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
  • Table 143 Spain Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
  • Table 144 Spain Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
  • Table 145 Russia Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%)
  • Table 146 Russia Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
  • Table 147 Russia Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
  • Table 148 Russia Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
  • Table 149 Russia Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
  • Table 150 Rest of Europe Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%)
  • Table 151 Rest of Europe Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
  • Table 152 Rest of Europe Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
  • Table 153 Rest of Europe Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
  • Table 154 Rest of Europe Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
  • Table 155 Asia Pacific Antiviral Drugs Treatment Market Forecast by Country, 2021-2031 (US$ bn, AGR%, CAGR%)
  • Table 156 Asia Pacific Antiviral Drugs Treatment Market Forecast by Drug Class, 2021-2031 (US$ bn, AGR%, CAGR%)
  • Table 157 Asia Pacific Antiviral Drugs Treatment Market Forecast by Drug Class, 2021-2031 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
  • Table 158 Asia Pacific Antiviral Drugs Treatment Market Forecast by Drug Class, 2021-2031 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
  • Table 159 Asia Pacific Antiviral Drugs Treatment Market Forecast by Drug Class, 2021-2031 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
  • Table 160 Asia Pacific Antiviral Drugs Treatment Market Forecast by Drug Class, 2021-2031 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
  • Table 161 Asia Pacific Antiviral Drugs Treatment Market Forecast by Application, 2021-2031 (US$ bn, AGR%, CAGR %)
  • Table 162 Asia Pacific Antiviral Drugs Treatment Market Forecast by Application, 2021-2031 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
  • Table 163 Asia Pacific Antiviral Drugs Treatment Market Forecast by Application, 2021-2031 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
  • Table 164 Asia Pacific Antiviral Drugs Treatment Market Forecast by Application, 2021-2031 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
  • Table 165 Asia Pacific Antiviral Drugs Treatment Market Forecast by Application, 2021-2031 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
  • Table 166 Asia Pacific Antiviral Drugs Treatment Market Forecast by End User, 2021-2031 (US$ bn, AGR%, CAGR%)
  • Table 167 Asia Pacific Antiviral Drugs Treatment Market Forecast by End User, 2021-2031 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
  • Table 168 Asia Pacific Antiviral Drugs Treatment Market Forecast by End User, 2021-2031 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
  • Table 169 Asia Pacific Antiviral Drugs Treatment Market Forecast by End User, 2021-2031 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
  • Table 170 Asia Pacific Antiviral Drugs Treatment Market Forecast by End User, 2021-2031 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
  • Table 171 Japan Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%)
  • Table 172 Japan Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
  • Table 173 Japan Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
  • Table 174 Japan Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
  • Table 175 Japan Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
  • Table 176 China Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%)
  • Table 177 China Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
  • Table 178 China Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
  • Table 179 China Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
  • Table 180 China Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
  • Table 181 India Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%)
  • Table 182 India Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
  • Table 183 India Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
  • Table 184 India Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
  • Table 185 India Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
  • Table 186 Australia Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%)
  • Table 187 Australia Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
  • Table 188 Australia Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
  • Table 189 Australia Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
  • Table 190 Australia Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
  • Table 191 South Korea Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%)
  • Table 192 South Korea Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
  • Table 193 South Korea Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
  • Table 194 South Korea Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
  • Table 195 South Korea Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
  • Table 196 Rest of Asia Pacific Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%)
  • Table 197 Rest of Asia Pacific Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
  • Table 198 Rest of Asia Pacific Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
  • Table 199 Rest of Asia Pacific Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
  • Table 200 Rest of Asia Pacific Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
  • Table 201 Latin America Antiviral Drugs Treatment Market Forecast by Country, 2021-2031 (US$ bn, AGR%, CAGR%)
  • Table 202 Latin America Antiviral Drugs Treatment Market Forecast by Drug Class, 2021-2031 (US$ bn, AGR%, CAGR%)
  • Table 203 Latin America Antiviral Drugs Treatment Market Forecast by Drug Class, 2021-2031 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
  • Table 204 Latin America Antiviral Drugs Treatment Market Forecast by Drug Class, 2021-2031 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
  • Table 205 Latin America Antiviral Drugs Treatment Market Forecast by Drug Class, 2021-2031 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
  • Table 206 Latin America Antiviral Drugs Treatment Market Forecast by Drug Class, 2021-2031 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
  • Table 207 Latin America Antiviral Drugs Treatment Market Forecast by Application, 2021-2031 (US$ bn, AGR%, CAGR%)
  • Table 208 Latin America Antiviral Drugs Treatment Market Forecast by Application, 2021-2031 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
  • Table 209 Latin America Antiviral Drugs Treatment Market Forecast by Application, 2021-2031 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
  • Table 210 Latin America Antiviral Drugs Treatment Market Forecast by Application, 2021-2031 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
  • Table 211 Latin America Antiviral Drugs Treatment Market Forecast by Drug Class, 2021-2031 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
  • Table 212 Latin America Antiviral Drugs Treatment Market Forecast by End User, 2021-2031 (US$ bn, AGR%, CAGR%)
  • Table 213 Latin America Antiviral Drugs Treatment Market Forecast by End User, 2021-2031 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
  • Table 214 Latin America Antiviral Drugs Treatment Market Forecast by End User, 2021-2031 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
  • Table 215 Latin America Antiviral Drugs Treatment Market Forecast by End User, 2021-2031 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
  • Table 216 Latin America Antiviral Drugs Treatment Market Forecast by End User, 2021-2031 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
  • Table 217 Brazil Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%)
  • Table 218 Brazil Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
  • Table 219 Brazil Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
  • Table 220 Brazil Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
  • Table 221 Brazil Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
  • Table 222 Mexico Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR %)
  • Table 223 Mexico Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
  • Table 224 Mexico Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
  • Table 225 Mexico Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
  • Table 226 Mexico Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
  • Table 227 Rest of Latin America Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%)
  • Table 228 Rest of Latin America Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
  • Table 229 Rest of Latin America Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
  • Table 230 Rest of Latin America Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
  • Table 231 Rest of Latin America Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
  • Table 232 Middle East and Africa Antiviral Drugs Treatment Market Forecast by Country, 2021-2031 (US$ bn, AGR%, CAGR%)
  • Table 233 Middle East and Africa Antiviral Drugs Treatment Market Forecast by Drug Class, 2021-2031 (US$ bn, AGR%, CAGR%)
  • Table 234 Middle East and Africa Antiviral Drugs Treatment Market Forecast by Drug Class, 2021-2031 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
  • Table 235 Middle East and Africa Antiviral Drugs Treatment Market Forecast by Drug Class, 2021-2031 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
  • Table 236 Middle East and Africa Antiviral Drugs Treatment Market Forecast by Drug Class, 2021-2031 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
  • Table 237 Middle East and Africa Antiviral Drugs Treatment Market Forecast by Drug Class, 2021-2031 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
  • Table 238 Middle East and Africa Antiviral Drugs Treatment Market Forecast by Application, 2021-2031 (US$ bn, AGR%, CAGR%)
  • Table 239 Middle East and Africa Antiviral Drugs Treatment Market Forecast by Application, 2021-2031 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
  • Table 240 Middle East and Africa Antiviral Drugs Treatment Market Forecast by Application, 2021-2031 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
  • Table 241 Middle East and Africa Antiviral Drugs Treatment Market Forecast by Application, 2021-2031 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
  • Table 242 Middle East and Africa Antiviral Drugs Treatment Market Forecast by Drug Class, 2021-2031 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
  • Table 243 Middle East and Africa Antiviral Drugs Treatment Market Forecast by End User, 2021-2031 (US$ bn, AGR%, CAGR%)
  • Table 244 Middle East and Africa Antiviral Drugs Treatment Market Forecast by End User, 2021-2031 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
  • Table 245 Middle East and Africa Antiviral Drugs Treatment Market Forecast by End User, 2021-2031 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
  • Table 246 Middle East and Africa Antiviral Drugs Treatment Market Forecast by End User, 2021-2031 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
  • Table 247 Middle East and Africa Antiviral Drugs Treatment Market Forecast by End User, 2021-2031 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
  • Table 248 South Africa Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%)
  • Table 249 South Africa Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
  • Table 250 South Africa Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
  • Table 251 South Africa Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
  • Table 252 South Africa Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
  • Table 253 GCC Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%)
  • Table 254 GCC Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
  • Table 255 GCC Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
  • Table 256 GCC Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
  • Table 257 GCC Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
  • Table 258 Rest of Middle East and Africa Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%)
  • Table 259 Rest of Middle East and Africa Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
  • Table 260 Rest of Middle East and Africa Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
  • Table 261 Rest of Middle East and Africa Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
  • Table 262 Rest of Middle East and Africa Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
  • Table 263 Antiviral Drugs Market Recent Developments, 2017-2020
  • Table 264 AbbVie Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 265 AbbVie Inc.: Product Benchmarking
  • Table 266 AbbVie Inc.: Recent Developments, 2017-2020
  • Table 267 F. Hoffmann-La Roche Ltd: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 268 F. Hoffmann-La Roche Ltd. .: Product Benchmarking
  • Table 269 F. Hoffmann -La Roche Ltd. : Recent Developments, 2017-2020
  • Table 270 Gilead Sciences, Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 271 Gilead Sciences, Inc. Product Benchmarking
  • Table 272 Gilead Sciences Inc. Recent Developments, 2017-2020
  • Table 273 Boehringer Ingelheim International GmbH: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 274 Boehringer Ingelheim International GmbH: Product Benchmarking
  • Table 275 Boehringer Ingelheim International GmbH; Recent Developments, 2017-2020
  • Table 276 AstraZeneca: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 277 AstraZeneca; Product Benchmarking
  • Table 278 AstraZeneca Recent Developments, 2017-2020
  • Table 279 GlaxoSmithKline plc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 280 GlaxoSmithKline plc.; Product Benchmarking
  • Table 281 GlaxoSmithKline plc.: Recent Developments, 2017-2020
  • Table 282 Novartis AG : Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 283 Novartis AG: Product Benchmarking
  • Table 284 Novartis AG: Recent Developments, 2017-2020
  • Table 285 Merck & Co., Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 286 Merck & Co., Inc.: Product Benchmarking
  • Table 287 Merck & Co., Inc.: Recent Developments, 2017-2020
  • Table 288 Bristol-Myers Squibb Company: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 289 Bristol-Myers Squibb Company: Product Benchmarking
  • Table 290 Bristol-Myers Squibb Company: Recent Developments, 2017-2020
  • Table 291 Johnson & Johnson Services, Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 292 Johnson & Johnson Services, Inc.: Product Benchmarking
  • Table 293 Johnson & Johnson Services, Inc.: Recent Developments, 2017-2020
  • Table 294 Cipla Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 295 Cipla Inc.: Product Benchmarking
  • Table 296 Cipla Inc.: Recent Developments, 2017-2020
  • Table 297 Abbott: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 298 Abbott: Product Benchmarking

List of Figures

  • Figure 1 Global Anti-Viral Drugs Market Size Forecast 2021-2031 (US$Bn, AGR %)
  • Figure 2 Global Antiviral Drugs Treatment Market Segmentation
  • Figure 3 Global Antiviral Drugs Treatment Market: Market Trends
  • Figure 4 Global Antiviral Drugs Treatment Market: Porter's Five Forces Analysis
  • Figure 5 Global Antiviral Drugs Treatment Market: PEST Analysis
  • Figure 6 Global Antiviral Drugs Treatment Market Forecast by Drug Class, 2021-2031 (US$ billion, AGR %)
  • Figure 7 Global Antiviral Drugs Treatment Market Share Forecast by Drug Class, 2021, 2026, 2031 (%)
  • Figure 8 Global Antiviral Drugs Treatment Market for Reverse Transcriptase Inhibitors Segment: Revenue Forecast 2021-2031 (US$ billion, AGR%)
  • Figure 9 Global Antiviral Drugs Treatment Market for Reverse Transcriptase Inhibitors Segment, Revenue Forecast 2021-2031 (US$ billion, AGR%): "V" Shaped Recovery
  • Figure 10 Global Antiviral Drugs Treatment Market for Reverse Transcriptase Inhibitors Segment, Revenue Forecast 2021-2031 (US$ billion, AGR%): "U" Shaped Recovery
  • Figure 11 Global Antiviral Drugs Treatment Market for Reverse Transcriptase Inhibitor Segment, Revenue Forecast 2021-2031 (US$ billion, AGR%): "W" Shaped Recovery
  • Figure 12 Global Antiviral Drugs Treatment Market for Reverse Transcriptase Inhibitor Segment, Revenue Forecast 2021-2031 (US$ billion, AGR%): "L" Shaped Recovery
  • Figure 13 Global Antiviral Drugs Treatment Market for Protease Inhibitors Segment: Revenue Forecast 2021-2031 (US$ billion, AGR%)
  • Figure 14 Global Antiviral Drugs Treatment Market for Protease Inhibitors Segment, Revenue Forecast 2021-2031 (US$ billion, AGR%): "V" Shaped Recovery
  • Figure 15 Global Antiviral Drugs Treatment Market for Protease Inhibitors Segment, Revenue Forecast 2021-2031 (US$ billion, AGR%): "U" Shaped Recovery
  • Figure 16 Global Antiviral Drugs Treatment Market for Protease Inhibitor Segment, Revenue Forecast 2021-2031 (US$ billion, AGR%): "W" Shaped Recovery
  • Figure 17 Global Antiviral Drugs Treatment Market for Protease Inhibitor Segment, Revenue Forecast 2021-2031 (US$ billion, AGR%): "L" Shaped Recovery
  • Figure 18 Global Antiviral Drugs Treatment Market for DNA Polymerase Inhibitors Segment: Revenue Forecast 2021-2031 (US$ billion, AGR%)
  • Figure 19 Global Antiviral Drugs Treatment Market for DNA Polymerase Inhibitors Segment, Revenue Forecast 2021-2031 (US$ billion, AGR%): "V" Shaped Recovery
  • Figure 20 Global Antiviral Drugs Treatment Market for DNA Polymerase Inhibitors Segment, Revenue Forecast 2021-2031 (US$ billion, AGR%): "U" Shaped Recovery
  • Figure 21 Global Antiviral Drugs Treatment Market for DNA Polymerase Inhibitor Segment, Revenue Forecast 2021-2031 (US$ billion, AGR%): "W" Shaped Recovery
  • Figure 22 Global Antiviral Drugs Treatment Market for DNA Polymerase Inhibitor Segment, Revenue Forecast 2021-2031 (US$ billion, AGR%): "L" Shaped Recovery
  • Figure 23 Global Antiviral Drugs Treatment Market for Neuraminidase Inhibitors Segment: Revenue Forecast 2021-2031 (US$ billion, AGR%)
  • Figure 24 Global Antiviral Drugs Treatment Market for Neuraminidase Inhibitors Segment, Revenue Forecast 2021-2031 (US$ billion, AGR%): "V" Shaped Recovery
  • Figure 25 Global Antiviral Drugs Treatment Market for Neuraminidase Inhibitors Segment, Revenue Forecast 2021-2031 (US$ billion, AGR%): "U" Shaped Recovery
  • Figure 26 Global Antiviral Drugs Treatment Market for Neuraminidase Inhibitor Segment, Revenue Forecast 2021-2031 (US$ billion, AGR%): "W" Shaped Recovery
  • Figure 27 Global Antiviral Drugs Treatment Market for Neuraminidase Inhibitor Segment, Revenue Forecast 2021-2031 (US$ billion, AGR%): "L" Shaped Recovery
  • Figure 28 Global Antiviral Drugs Treatment Market for Others Segment: Revenue Forecast 2021-2031 (US$ billion, AGR%)
  • Figure 29 Global Antiviral Drugs Treatment Market for Others Segment, Revenue Forecast 2021-2031 (US$ billion, AGR%): "V" Shaped Recovery
  • Figure 30 Global Antiviral Drugs Treatment Market for Others Segment, Revenue Forecast 2021-2031 (US$ billion, AGR%): "U" Shaped Recovery
  • Figure 31 Global Antiviral Drugs Treatment Market for Others Segment, Revenue Forecast 2021-2031 (US$ billion, AGR%): "W" Shaped Recovery
  • Figure 32 Global Antiviral Drugs Treatment Market for Others Segment, Revenue Forecast 2021-2031 (US$ billion, AGR%): "L" Shaped Recovery
  • Figure 33 Global Antiviral Drugs Treatment Market Forecast by Application, 2021-2031 (US$ billion, AGR %)
  • Figure 34 Global Antiviral Drugs Treatment Market Share Forecast by Application, 2021, 2026, 2031 (%)
  • Figure 35 Global Antiviral Drugs Treatment Market for Hepatitis Segment: Revenue Forecast 2021-2031 (US$ billion, AGR%)
  • Figure 36 Global Antiviral Drugs Treatment Market for Hepatitis Segment, Revenue Forecast 2021-2031 (US$ billion, AGR%): "V" Shaped Recovery
  • Figure 37 Global Antiviral Drugs Treatment Market for Hepatitis Segment, Revenue Forecast 2021-2031 (US$ billion, AGR%): "U" Shaped Recovery
  • Figure 38 Global Antiviral Drugs Treatment Market for Hepatitis Segment, Revenue Forecast 2021-2031 (US$ billion, AGR%): "W" Shaped Recovery
  • Figure 39 Global Antiviral Drugs Treatment Market for Hepatitis Segment, Revenue Forecast 2021-2031 (US$ billion, AGR%): "L" Shaped Recovery
  • Figure 40 Global Antiviral Drugs Treatment Market for HIV Segment: Revenue Forecast 2021-2031 (US$ billion, AGR%)
  • Figure 41 Global Antiviral Drugs Treatment Market for HIV Segment, Revenue Forecast 2021-2031 (US$ billion, AGR%): "V" Shaped Recovery
  • Figure 42 Global Antiviral Drugs Treatment Market for HIV Segment, Revenue Forecast 2021-2031 (US$ billion, AGR%): "U" Shaped Recovery
  • Figure 43 Global Antiviral Drugs Treatment Market for HIV Segment, Revenue Forecast 2021-2031 (US$ billion, AGR%): "W" Shaped Recovery
  • Figure 44 Global Antiviral Drugs Treatment Market for HIV Segment, Revenue Forecast 2021-2031 (US$ billion, AGR%): "L" Shaped Recovery
  • Figure 45 Global Antiviral Drugs Treatment Market for Influenza Segment: Revenue Forecast 2021-2031 (US$ billion, AGR%)
  • Figure 46 Global Antiviral Drugs Treatment Market for Influenza Segment, Revenue Forecast 2021-2031 (US$ billion, AGR%): "V" Shaped Recovery
  • Figure 47 Global Antiviral Drugs Treatment Market for Influenza Segment, Revenue Forecast 2021-2031 (US$ billion, AGR%): "U" Shaped Recovery
  • Figure 48 Global Antiviral Drugs Treatment Market for Influenza Segment, Revenue Forecast 2021-2031 (US$ billion, AGR%): "W" Shaped Recovery
  • Figure 49 Global Antiviral Drugs Treatment Market for Influenza Segment, Revenue Forecast 2021-2031 (US$ billion, AGR%): "L" Shaped Recovery
  • Figure 50 Global Antiviral Drugs Treatment Market for Herpes Segment: Revenue Forecast 2021-2031 (US$ billion, AGR%)
  • Figure 51 Global Antiviral Drugs Treatment Market for Herpes Segment, Revenue Forecast 2021-2031 (US$ billion, AGR%): "V" Shaped Recovery
  • Figure 52 Global Antiviral Drugs Treatment Market for Herpes Segment, Revenue Forecast 2021-2031 (US$ billion, AGR%): "U" Shaped Recovery
  • Figure 53 Global Antiviral Drugs Treatment Market for Herpes Segment, Revenue Forecast 2021-2031 (US$ billion, AGR%): "W" Shaped Recovery
  • Figure 54 Global Antiviral Drugs Treatment Market for Herpes Segment, Revenue Forecast 2021-2031 (US$ billion, AGR%): "L" Shaped Recovery
  • Figure 55 Global Antiviral Drugs Treatment Market for Others Segment: Revenue Forecast 2021-2031 (US$ billion, AGR%)
  • Figure 56 Global Antiviral Drugs Treatment Market for Others Segment, Revenue Forecast 2021-2031 (US$ billion, AGR%): "V" Shaped Recovery
  • Figure 57 Global Antiviral Drugs Treatment Market for Others Segment, Revenue Forecast 2021-2031 (US$ billion, AGR%): "U" Shaped Recovery
  • Figure 58 Global Antiviral Drugs Treatment Market for Others Segment, Revenue Forecast 2021-2031 (US$ billion, AGR%): "W" Shaped Recovery
  • Figure 59 Global Antiviral Drugs Treatment Market for Others Segment, Revenue Forecast 2021-2031 (US$ billion, AGR%): "L" Shaped Recovery
  • Figure 60 Global Antiviral Drugs Treatment Market Forecast by End User, 2021-2031 (US$ billion, AGR %)
  • Figure 61 Global Antiviral Drugs Treatment Market Share Forecast by End User, 2021, 2026, 2031 (%)
  • Figure 62 Global Antiviral Drugs Treatment Market for Hospital Segment: Revenue Forecast 2021-2031 (US$ billion, AGR%)
  • Figure 63 Global Antiviral Drugs Treatment Market for Hospital Segment, Revenue Forecast 2021-2031 (US$ billion, AGR%): "V" Shaped Recovery
  • Figure 64 Global Antiviral Drugs Treatment Market for Hospital Segment, Revenue Forecast 2021-2031 (US$ billion, AGR%): "U" Shaped Recovery
  • Figure 65 Global Antiviral Drugs Treatment Market for Hospital Segment, Revenue Forecast 2021-2031 (US$ billion, AGR%): "W" Shaped Recovery
  • Figure 66 Global Antiviral Drugs Treatment Market for Hospital Segment, Revenue Forecast 2021-2031 (US$ billion, AGR%): "L" Shaped Recovery
  • Figure 67 Global Antiviral Drugs Treatment Market for Clinics Segment: Revenue Forecast 2021-2031 (US$ billion, AGR%)
  • Figure 68 Global Antiviral Drugs Treatment Market for Clinics Segment, Revenue Forecast 2021-2031 (US$ billion, AGR%): "V" Shaped Recovery
  • Figure 69 Global Antiviral Drugs Treatment Market for Clinics Segment, Revenue Forecast 2021-2031 (US$ billion, AGR%): "U" Shaped Recovery
  • Figure 70 Global Antiviral Drugs Treatment Market for Clinics Segment, Revenue Forecast 2021-2031 (US$ billion, AGR%): "W" Shaped Recovery
  • Figure 71 Global Antiviral Drugs Treatment Market for Clinics Segment, Revenue Forecast 2021-2031 (US$ billion, AGR%): "L" Shaped Recovery
  • Figure 72 Global Antiviral Drugs Treatment Market for Others Segment: Revenue Forecast 2021-2031 (US$ billion, AGR%)
  • Figure 73 Global Antiviral Drugs Treatment Market for Others Segment, Revenue Forecast 2021-2031 (US$ billion, AGR%): "V" Shaped Recovery
  • Figure 74 Global Antiviral Drugs Treatment Market for Others Segment, Revenue Forecast 2021-2031 (US$ billion, AGR%): "U" Shaped Recovery
  • Figure 75 Global Antiviral Drugs Treatment Market for Others Segment, Revenue Forecast 2021-2031 (US$ billion, AGR%): "W" Shaped Recovery
  • Figure 76 Global Antiviral Drugs Treatment Market for Others Segment, Revenue Forecast 2021-2031 (US$ billion, AGR%): "L" Shaped Recovery
  • Figure 77 Global Antiviral Drugs Treatment Market Forecast by Region 2021-2031 (US$ billion)
  • Figure 78 Global Antiviral Drugs Treatment Market Share Forecast by Region 2021, 2026, 2031 (%)
  • Figure 79 Global Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ billion, AGR%): "V" Shaped Recovery
  • Figure 80 Global Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ billion, AGR%): "U" Shaped Recovery
  • Figure 81 Global Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ billion, AGR%): "W" Shaped Recovery
  • Figure 82 Global Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ billion, AGR%): "L" Shaped Recovery
  • Figure 83 North America Antiviral Drugs Treatment Market Forecast by Country 2021-2031 (US$ billion)
  • Figure 84 North America Antiviral Drugs Treatment Market Share Forecast by Country 2021, 2026, 2031 (%)
  • Figure 85 North America Antiviral Drugs Treatment Market Forecast by Drug Class, 2021-2031 (US$ billion, AGR%)
  • Figure 86 North America Antiviral Drugs Treatment Market Forecast by Product, 2021-2031 (US$ billion, AGR%): "V" Shaped Recovery
  • Figure 87 North America Antiviral Drugs Treatment Market Forecast by Product, 2021-2031 (US$ billion, AGR%): "U" Shaped Recovery
  • Figure 88 North America Antiviral Drugs Treatment Market Forecast by Product, 2021-2031 (US$ billion, AGR%): "W" Shaped Recovery
  • Figure 89 North America Antiviral Drugs Treatment Market Forecast by Product, 2021-2031 (US$ billion, AGR%): "L" Shaped Recovery
  • Figure 90 North America Antiviral Drugs Treatment Market Forecast by Application, 2021-2031 (US$ billion, AGR%)
  • Figure 91 North America Antiviral Drugs Treatment Market Forecast by Application, 2021-2031 (US$ billion, AGR%): "V" Shaped Recovery
  • Figure 92 North America Antiviral Drugs Treatment Market Forecast by Application, 2021-2031 (US$ billion, AGR%): "U" Shaped Recovery
  • Figure 93 North America Antiviral Drugs Treatment Market Forecast by Application, 2021-2031 (US$ billion, AGR%): "W" Shaped Recovery
  • Figure 94 North America Antiviral Drugs Treatment Market Forecast by Application, 2021-2031 (US$ billion, AGR%): "L" Shaped Recovery
  • Figure 95 North America Antiviral Drugs Treatment Market Forecast by End User, 2021-2031 (US$ billion, AGR%)
  • Figure 96 North America Antiviral Drugs Treatment Market Forecast by End User, 2021-2031 (US$ billion, AGR%): "V" Shaped Recovery
  • Figure 97 North America Antiviral Drugs Treatment Market Forecast by End User, 2021-2031 (US$ billion, AGR%): "U" Shaped Recovery
  • Figure 98 North America Antiviral Drugs Treatment Market Forecast by End User, 2021-2031 (US$ billion, AGR%): "W" Shaped Recovery
  • Figure 99 North America Antiviral Drugs Treatment Market Forecast by End User, 2021-2031 (US$ billion, AGR%): "L" Shaped Recovery
  • Figure 100 U.S. Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ billion, AGR %)
  • Figure 101 U.S. Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ billion, AGR%): "V" Shaped Recovery
  • Figure 102 U.S. Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ billion, AGR%): "U" Shaped Recovery
  • Figure 103 U.S. Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ billion, AGR%): "W" Shaped Recovery
  • Figure 104 U.S. Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ billion, AGR%): "L" Shaped Recovery
  • Figure 105 Canada Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ billion, AGR %)
  • Figure 106 Canada Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ billion, AGR%): "V" Shaped Recovery
  • Figure 107 Canada Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ billion, AGR%): "U" Shaped Recovery
  • Figure 108 Canada Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ billion, AGR%): "W" Shaped Recovery
  • Figure 109 Canada Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ billion, AGR%): "L" Shaped Recovery
  • Figure 110 Europe Antiviral Drugs Treatment Market Forecast by Country 2021-2031 (US$ billion)
  • Figure 111 Europe Antiviral Drugs Treatment Market Share Forecast by Country 2021, 2026, 2031 (%)
  • Figure 112 Europe Antiviral Drugs Treatment Market Forecast by Drug Class, 2021-2031 (US$ billion, AGR%)
  • Figure 113 Europe Antiviral Drugs Treatment Market Forecast by Drug Class, 2021-2031 (US$ billion, AGR%): "V" Shaped Recovery
  • Figure 114 Europe Antiviral Drugs Treatment Market Forecast by Drug Class, 2021-2031 (US$ billion, AGR%): "U" Shaped Recovery
  • Figure 115 Europe Antiviral Drugs Treatment Market Forecast by Drug Class, 2021-2031 (US$ billion, AGR%): "W" Shaped Recovery
  • Figure 116 Europe Antiviral Drugs Treatment Market Forecast by Drug Class, 2021-2031 (US$ billion, AGR%): "L" Shaped Recovery
  • Figure 117 Europe Antiviral Drugs Treatment Market Forecast by Application, 2021-2031 (US$ billion, AGR%)
  • Figure 118 Europe Antiviral Drugs Treatment Market Forecast by Application, 2021-2031 (US$ billion, AGR%): "V" Shaped Recovery
  • Figure 119 Europe Antiviral Drugs Treatment Market Forecast by Application, 2021-2031 (US$ billion, AGR%): "U" Shaped Recovery
  • Figure 120 Europe Antiviral Drugs Treatment Market Forecast by Application, 2021-2031 (US$ billion, AGR%): "W" Shaped Recovery
  • Figure 121 Europe Antiviral Drugs Treatment Market Forecast by Application, 2021-2031 (US$ billion, AGR%): "L" Shaped Recovery
  • Figure 122 Europe Antiviral Drugs Treatment Market Forecast by End User, 2021-2031 (US$ billion, AGR%)
  • Figure 123 Europe Antiviral Drugs Treatment Market Forecast by End User, 2021-2031 (US$ billion, AGR%): "V" Shaped Recovery
  • Figure 124 Europe Antiviral Drugs Treatment Market Forecast by End User, 2021-2031 (US$ billion, AGR%): "U" Shaped Recovery
  • Figure 125 Europe Antiviral Drugs Treatment Market Forecast by End User, 2021-2031 (US$ billion, AGR%): "W" Shaped Recovery
  • Figure 126 Europe Antiviral Drugs Treatment Market Forecast by End User, 2021-2031 (US$ billion, AGR%): "L" Shaped Recovery
  • Figure 127 Germany Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ billion, AGR %)
  • Figure 128 Germany Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ billion, AGR%): "V" Shaped Recovery
  • Figure 129 Germany Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ billion, AGR%): "U" Shaped Recovery
  • Figure 130 Germany Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ billion, AGR%): "W" Shaped Recovery
  • Figure 131 Germany Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ billion, AGR%): "L" Shaped Recovery
  • Figure 132 U.K. Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ billion, AGR %)
  • Figure 133 U.K. Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ billion, AGR%): "V" Shaped Recovery
  • Figure 134 U.K. Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ billion, AGR%): "U" Shaped Recovery
  • Figure 135 U.K. Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ billion, AGR%): "W" Shaped Recovery
  • Figure 136 U.K. Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ billion, AGR%): "L" Shaped Recovery
  • Figure 137 France Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ billion, AGR %)
  • Figure 138 France Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ billion, AGR%): "V" Shaped Recovery
  • Figure 139 France Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ billion, AGR%): "U" Shaped Recovery
  • Figure 140 France Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ billion, AGR%): "W" Shaped Recovery
  • Figure 141 France Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ billion, AGR%): "L" Shaped Recovery
  • Figure 142 Italy Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ billion, AGR %)
  • Figure 143 Italy Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ billion, AGR%): "V" Shaped Recovery
  • Figure 144 Italy Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ billion, AGR%): "U" Shaped Recovery
  • Figure 145 Italy Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ billion, AGR%): "W" Shaped Recovery
  • Figure 146 Italy Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ billion, AGR%): "L" Shaped Recovery
  • Figure 147 Spain Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ billion, AGR %)
  • Figure 148 Spain Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ billion, AGR%): "V" Shaped Recovery
  • Figure 149 Spain Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ billion, AGR%): "U" Shaped Recovery
  • Figure 150 Spain Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ billion, AGR%): "W" Shaped Recovery
  • Figure 151 Spain Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ billion, AGR%): "L" Shaped Recovery
  • Figure 152 Russia Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ billion, AGR %)
  • Figure 153 Russia Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ billion, AGR%): "V" Shaped Recovery
  • Figure 154 Russia Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ billion, AGR%): "U" Shaped Recovery
  • Figure 155 Russia Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ billion, AGR%): "W" Shaped Recovery
  • Figure 156 Russia Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ billion, AGR%): "L" Shaped Recovery
  • Figure 157 Rest of Europe Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ billion, AGR %)
  • Figure 158 Rest of Europe Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ billion, AGR%): "V" Shaped Recovery
  • Figure 159 Rest of Europe Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ billion, AGR%): "U" Shaped Recovery
  • Figure 160 Rest of Europe Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ billion, AGR%): "W" Shaped Recovery
  • Figure 161 Rest of Europe Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ billion, AGR%): "L" Shaped Recovery
  • Figure 162 Asia Pacific Antiviral Drugs Treatment Market Forecast by Country 2021-2031 (US$ billion)
  • Figure 163 Asia Pacific Antiviral Drugs Treatment Market Share Forecast by Country 2021, 2026, 2031 (%)
  • Figure 164 Asia Pacific Antiviral Drugs Treatment Market Forecast by Drug Class, 2021-2031 (US$ billion, AGR%)
  • Figure 165 Asia Pacific Antiviral Drugs Treatment Market Forecast by Drug Class, 2021-2031 (US$ billion, AGR%): "V" Shaped Recovery
  • Figure 166 Asia Pacific Antiviral Drugs Treatment Market Forecast by Drug Class, 2021-2031 (US$ billion, AGR%): "U" Shaped Recovery
  • Figure 167 Asia Pacific Antiviral Drugs Treatment Market Forecast by Drug Class, 2021-2031 (US$ billion, AGR%): "W" Shaped Recovery
  • Figure 168 Asia Pacific Antiviral Drugs Treatment Market Forecast by Drug Class, 2021-2031 (US$ billion, AGR%): "L" Shaped Recovery
  • Figure 169 Asia Pacific Antiviral Drugs Treatment Market Forecast by Application, 2021-2031 (US$ billion, AGR%)
  • Figure 170 Asia Pacific Antiviral Drugs Treatment Market Forecast by Application, 2021-2031 (US$ billion, AGR%): "V" Shaped Recovery
  • Figure 171 Asia Pacific Antiviral Drugs Treatment Market Forecast by Application, 2021-2031 (US$ billion, AGR%): "U" Shaped Recovery
  • Figure 172 Asia Pacific Antiviral Drugs Treatment Market Forecast by Application, 2021-2031 (US$ billion, AGR%): "W" Shaped Recovery
  • Figure 173 Asia Pacific Antiviral Drugs Treatment Market Forecast by Application, 2021-2031 (US$ billion, AGR%): "L" Shaped Recovery
  • Figure 174 Asia Pacific Antiviral Drugs Treatment Market Forecast by End User, 2021-2031 (US$ billion, AGR%)
  • Figure 175 Asia Pacific Antiviral Drugs Treatment Market Forecast by End User, 2021-2031 (US$ billion, AGR%): "V" Shaped Recovery
  • Figure 176 Asia Pacific Antiviral Drugs Treatment Market Forecast by End User, 2021-2031 (US$ billion, AGR%): "U" Shaped Recovery
  • Figure 177 Asia Pacific Antiviral Drugs Treatment Market Forecast by End User, 2021-2031 (US$ billion, AGR%): "W" Shaped Recovery
  • Figure 178 Asia Pacific Antiviral Drugs Treatment Market Forecast by End User, 2021-2031 (US$ billion, AGR%): "L" Shaped Recovery
  • Figure 179 Japan Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ billion, AGR %)
  • Figure 180 Japan Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ billion, AGR%): "V" Shaped Recovery
  • Figure 181 Japan Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ billion, AGR%): "U" Shaped Recovery
  • Figure 182 Japan Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ billion, AGR%): "W" Shaped Recovery
  • Figure 183 Japan Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ billion, AGR%): "L" Shaped Recovery
  • Figure 184 China Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ billion, AGR %)
  • Figure 185 China Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ billion, AGR%): "V" Shaped Recovery
  • Figure 186 China Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ billion, AGR%): "U" Shaped Recovery
  • Figure 187 China Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ billion, AGR%): "W" Shaped Recovery
  • Figure 188 China Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ billion, AGR%): "L" Shaped Recovery
  • Figure 189 India Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ billion, AGR %)
  • Figure 190 India Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ billion, AGR%): "V" Shaped Recovery
  • Figure 191 India Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ billion, AGR%): "U" Shaped Recovery
  • Figure 192 India Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ billion, AGR%): "W" Shaped Recovery
  • Figure 193 India Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ billion, AGR%): "L" Shaped Recovery
  • Figure 194 Australia Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ billion, AGR %)
  • Figure 195 Australia Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ billion, AGR%): "V" Shaped Recovery
  • Figure 196 Australia Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ billion, AGR%): "U" Shaped Recovery
  • Figure 197 Australia Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ billion, AGR%): "W" Shaped Recovery
  • Figure 198 Australia Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ billion, AGR%): "L" Shaped Recovery
  • Figure 199 South Korea Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ billion, AGR %)
  • Figure 200 South Korea Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ billion, AGR%): "V" Shaped Recovery
  • Figure 201 South Korea Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ billion, AGR%): "U" Shaped Recovery
  • Figure 202 South Korea Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ billion, AGR%): "W" Shaped Recovery
  • Figure 203 South Korea Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ billion, AGR%): "L" Shaped Recovery
  • Figure 204 Rest of Asia Pacific Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ billion, AGR %)
  • Figure 205 Rest of Asia Pacific Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ billion, AGR%): "V" Shaped Recovery
  • Figure 206 Rest of Asia Pacific Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ billion, AGR%): "U" Shaped Recovery
  • Figure 207 Rest of Asia Pacific Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ billion, AGR%): "W" Shaped Recovery
  • Figure 208 Rest of Asia Pacific Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ billion, AGR%): "L" Shaped Recovery
  • Figure 209 Latin America Antiviral Drugs Treatment Market Forecast by Country 2021-2031 (US$ billion)
  • Figure 210 Latin America Antiviral Drugs Treatment Market Share Forecast by Country 2021, 2026, 2031 (%)
  • Figure 211 Latin America Antiviral Drugs Treatment Market Forecast by Drug Class, 2021-2031 (US$ billion, AGR%)
  • Figure 212 Latin America Antiviral Drugs Treatment Market Forecast by Drug Class, 2021-2031 (US$ billion, AGR%): "V" Shaped Recovery
  • Figure 213 Latin America Antiviral Drugs Treatment Market Forecast by Drug Class, 2021-2031 (US$ billion, AGR%): "U" Shaped Recovery
  • Figure 214 Latin America Antiviral Drugs Treatment Market Forecast by Drug Class, 2021-2031 (US$ billion, AGR%): "W" Shaped Recovery
  • Figure 215 Latin America Antiviral Drugs Treatment Market Forecast by Drug Class, 2021-2031 (US$ billion, AGR%): "L" Shaped Recovery
  • Figure 216 Latin America Antiviral Drugs Treatment Market Forecast by Application, 2021-2031 (US$ billion, AGR%)
  • Figure 217 Latin America Antiviral Drugs Treatment Market Forecast by Application, 2021-2031 (US$ billion, AGR%): "V" Shaped Recovery
  • Figure 218 Latin America Antiviral Drugs Treatment Market Forecast by Application, 2021-2031 (US$ billion, AGR%): "U" Shaped Recovery
  • Figure 219 Latin America Antiviral Drugs Treatment Market Forecast by Application, 2021-2031 (US$ billion, AGR%): "W" Shaped Recovery
  • Figure 220 Latin America Antiviral Drugs Treatment Market Forecast by Application, 2021-2031 (US$ billion, AGR%): "L" Shaped Recovery
  • Figure 221 Latin America Antiviral Drugs Treatment Market Forecast by End User, 2021-2031 (US$ billion, AGR%)
  • Figure 222 Latin America Antiviral Drugs Treatment Market Forecast by End User, 2021-2031 (US$ billion, AGR%): "V" Shaped Recovery
  • Figure 223 Latin America Antiviral Drugs Treatment Market Forecast by End User, 2021-2031 (US$ billion, AGR%): "U" Shaped Recovery
  • Figure 224 Latin America Antiviral Drugs Treatment Market Forecast by End User, 2021-2031 (US$ billion, AGR%): "W" Shaped Recovery
  • Figure 225 Latin America Antiviral Drugs Treatment Market Forecast by End User, 2021-2031 (US$ billion, AGR%): "L" Shaped Recovery
  • Figure 226 Brazil Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ billion, AGR %)
  • Figure 227 Brazil Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ billion, AGR%): "V" Shaped Recovery
  • Figure 228 Brazil Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ billion, AGR%): "U" Shaped Recovery
  • Figure 229 Brazil Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ billion, AGR%): "W" Shaped Recovery
  • Figure 230 Brazil Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ billion, AGR%): "L" Shaped Recovery
  • Figure 231 Mexico Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ billion, AGR %)
  • Figure 232 Mexico Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ billion, AGR%): "V" Shaped Recovery
  • Figure 233 Mexico Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ billion, AGR%): "U" Shaped Recovery
  • Figure 234 Mexico Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ billion, AGR%): "W" Shaped Recovery
  • Figure 235 Mexico Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ billion, AGR%): "L" Shaped Recovery
  • Figure 236 Rest of Latin America Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ billion, AGR %)
  • Figure 237 Rest of Latin America Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ billion, AGR%): "V" Shaped Recovery
  • Figure 238 Rest of Latin America Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ billion, AGR%): "U" Shaped Recovery
  • Figure 239 Rest of Latin America Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ billion, AGR%): "W" Shaped Recovery
  • Figure 240 Rest of Latin America Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ billion, AGR%): "L" Shaped Recovery
  • Figure 241 Middle East and Africa Antiviral Drugs Treatment Market Forecast by Country 2021-2031 (US$ billion)
  • Figure 242 Middle East and Africa Antiviral Drugs Treatment Market Share Forecast by Country 2021, 2026, 2031 (%)
  • Figure 243 Middle East and Africa Antiviral Drugs Treatment Market Forecast by Drug Class, 2021-2031 (US$ billion, AGR %)
  • Figure 244 Middle East and Africa Antiviral Drugs Treatment Market Forecast by Drug Class, 2021-2031 (US$ billion, AGR%): "V" Shaped Recovery
  • Figure 245 Middle East and Africa Antiviral Drugs Treatment Market Forecast by Drug Class, 2021-2031 (US$ billion, AGR%): "U" Shaped Recovery
  • Figure 246 Middle East and Africa Antiviral Drugs Treatment Market Forecast by Drug Class, 2021-2031 (US$ billion, AGR%): "W" Shaped Recovery
  • Figure 247 Middle East and Africa Antiviral Drugs Treatment Market Forecast by Drug Class, 2021-2031 (US$ billion, AGR%): "L" Shaped Recovery
  • Figure 248 Middle East and Africa Antiviral Drugs Treatment Market Forecast by Application, 2021-2031 (US$ billion, AGR%)
  • Figure 249 Middle East and Africa Antiviral Drugs Treatment Market Forecast by Application, 2021-2031 (US$ billion, AGR%): "V" Shaped Recovery
  • Figure 250 Middle East and Africa Antiviral Drugs Treatment Market Forecast by Application, 2021-2031 (US$ billion, AGR%): "U" Shaped Recovery
  • Figure 251 Middle East and Africa Antiviral Drugs Treatment Market Forecast by Application, 2021-2031 (US$ billion, AGR%): "W" Shaped Recovery
  • Figure 252 Middle East and Africa Antiviral Drugs Treatment Market Forecast by Application, 2021-2031 (US$ billion, AGR%): "L" Shaped Recovery
  • Figure 253 Middle East and Africa Antiviral Drugs Treatment Market Forecast by End User, 2021-2031 (US$ billion, AGR%)
  • Figure 254 Middle East and Africa Antiviral Drugs Treatment Market Forecast by End User, 2021-2031 (US$ billion, AGR%): "V" Shaped Recovery
  • Figure 255 Middle East and Africa Antiviral Drugs Treatment Market Forecast by End User, 2021-2031 (US$ billion, AGR%): "U" Shaped Recovery
  • Figure 256 Middle East and Africa Antiviral Drugs Treatment Market Forecast by End User, 2021-2031 (US$ billion, AGR%): "W" Shaped Recovery
  • Figure 257 Middle East and Africa Antiviral Drugs Treatment Market Forecast by End User, 2021-2031 (US$ billion, AGR%): "L" Shaped Recovery
  • Figure 258 South Africa Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ billion, AGR %)
  • Figure 259 South Africa Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ billion, AGR%): "V" Shaped Recovery
  • Figure 260 South Africa Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ billion, AGR%): "U" Shaped Recovery
  • Figure 261 South Africa Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ billion, AGR%): "W" Shaped Recovery
  • Figure 262 South Africa Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ billion, AGR%): "L" Shaped Recovery
  • Figure 263 GCC Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ billion, AGR %)
  • Figure 264 GCC Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ billion, AGR%): "V" Shaped Recovery
  • Figure 265 GCC Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ billion, AGR%): "U" Shaped Recovery
  • Figure 266 GCC Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ billion, AGR%): "W" Shaped Recovery
  • Figure 267 GCC Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ billion, AGR%): "L" Shaped Recovery
  • Figure 268 Rest of Middle East and Africa Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ billion, AGR %)
  • Figure 269 Rest of Middle East and Africa Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ billion, AGR%): "V" Shaped Recovery
  • Figure 270 Rest of Latin America Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ billion, AGR%): "U" Shaped Recovery
  • Figure 271 Rest of Middle East and Africa Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ billion, AGR%): "W" Shaped Recovery
  • Figure 272 Rest of Middle East and Africa Antiviral Drugs Treatment Market Forecast, 2021-2031 (US$ billion, AGR%): "L" Shaped Recovery
  • Figure 273 Global Antiviral Drugs Treatment Market: Company Share Analysis 2019
  • Figure 274 AbbVie Inc.: Net Revenue, 2015-2019 (US$ billion, AGR%)
  • Figure 275 AbbVie Inc.: Product Revenue Shares, 2019
  • Figure 276 AbbVie Inc.: Regional Revenue Shares, 2019
  • Figure 277 F. Hoffmann - La Roche Ltd.: Net Revenue, 2015-2019 (US$ billion, AGR%)
  • Figure 278 F. Hoffmann- La Roche Ltd: Product Revenue Shares, 2019
  • Figure 279 F. Hoffmann- La Roche Ltd: Regional Revenue Shares, 2019
  • Figure 280 Gilead Sciences, Inc.: Net Revenue, 2015-2019 (US$ billion, AGR%)
  • Figure 281 Gilead Sciences, Inc.: Product Revenue Shares, 2019
  • Figure 282 Gilead Sciences, Inc.: Regional Revenue Shares, 2019
  • Figure 283 Boehringer Ingelheim Internatinal GmbH : Net Revenue, 2015-2019 (US$ billion, AGR%)
  • Figure 284 Boehringer Ingelheim International GmbH Product Revenue Shares, 2019
  • Figure 285 Boehringer Ingelheim International GmbH: Regional Revenue Shares, 2019
  • Figure 286 AstraZeneca: Net Revenue, 2015-2019 (US$ billion, AGR%)
  • Figure 287 AstraZeneca: Product Revenue Shares, 2019
  • Figure 288 AstraZeneca: Regional Revenue Shares, 2019
  • Figure 289 GlaxoSmithKline plc. Net Revenue, 2015-2019 (US$ billion, AGR%)
  • Figure 290 GlaxoSmithKline plc.: Product Revenue Shares, 2019
  • Figure 291 GlaxoSmithKline plc.: Regional Revenue Shares, 2019
  • Figure 292 Novartis AG: Net Revenue, 2015-2019 (US$ billion, AGR%)
  • Figure 293 Novartis AG: Product Revenue Shares, 2019
  • Figure 294 Novartis AG: Regional Revenue Shares, 2019
  • Figure 295 Merck & Co., Inc.: Net Revenue, 2015-2019 (US$ billion, AGR%)
  • Figure 296 Merck & Co., Inc.: Product Revenue Shares, 2019
  • Figure 297 Merck & Co., Inc.: Regional Revenue Shares, 2019
  • Figure 298 Bristol -Myers Squibb Company: Net Revenue, 2015-2019 (US$ billion, AGR%)
  • Figure 299 Bristol -Myers Squibb Company: Regional Revenue Shares, 2019
  • Figure 300 Johnson & Johnson Services Inc.: Net Revenue, 2015-2019 (US$ billion, AGR%)
  • Figure 301 Johnson & Johnson Services Inc.: Product Revenue Shares, 2019
  • Figure 302 Johnson & Johnson Services Inc.: Regional Revenue Shares, 2019
  • Figure 303 Cipla Inc.: Net Revenue, 2015-2019 (US$ billion, AGR%)
  • Figure 304 Cipla Inc.: Regional Revenue Shares, 2019
  • Figure 305 Abbott: Net Revenue, 2015-2019 (US$ billion, AGR%)
  • Figure 306 Abbott: Product Revenue Shares, 2019
  • Figure 307 Abbott: Regional Revenue Shares, 2019
  • Figure 308 Global Antiviral Drugs Treatment Market Share Forecast by Region, 2021, 2026, 2031 (%)

Companies Profiled in the Report:

  • Abbott Laboratories
  • AbbVie
  • AstraZeneca AB,
  • Boehringer Ingelheim Corporation
  • Bristol-Myers-Squibb,
  • Cipla Inc.
  • F. Hoffmann-La Roche Ltd
  • Gilead Sciences Inc.
  • GlaxoSmithKline,
  • Johnson & Johnson
  • Merck & Co
  • Novartis AG

List of Companies Mentioned in the Report:

  • Abbott Laboratories
  • AbbVie
  • Alexion Pharmaceuticals
  • Allergan
  • Alvotech
  • Amblyotech
  • ArQule, Inc.
  • Astex Pharmaceuticals
  • AstraZeneca AB,
  • Atea Pharmaceuticals, Inc.
  • Auris Health, Inc.
  • Aurobindo Pharma
  • Blueprint Medicines Corporation
  • Boehringer Ingelheim Corporation
  • Bristol-Myers-Squibb,
  • Cadent Therapeutics
  • Catalent Inc.
  • Cipla Inc.
  • Coalition for Epidemic Preparedness Innovations
  • Daiichi Sankyo
  • DR. CI:LABO
  • Dr. Reddy's Laboratories Ltd.
  • F. Hoffmann-La Roche Ltd
  • Forbius
  • Forty Seven, Inc.
  • Gedeon Richter Plc.
  • Gilead Sciences Inc.
  • GlaxoSmithKline,
  • Gritstone Oncology
  • Immunomedics, Inc.
  • Inflazome
  • Johnson & Johnson
  • Merck & Co
  • MyoKardia
  • MYR GmbH
  • NBE-Therapeutics
  • Northern Biologics Inc.
  • Novartis
  • Novartis AG
  • OncoImmune
  • Otsuka Pharmaceutical Co., Ltd.
  • Pandion Therapeutics, Inc.
  • Premier Medical Corporation
  • Samsung Biologics
  • SHIONOGI Co., Ltd.
  • Spark Therapeutics, Inc.
  • Stratos Genomics
  • Taiho Pharmaceutical Co, Ltd.
  • The Medicines Company
  • Themis
  • Vedere Bio
  • VelosBio Inc
  • Verb Surgical Inc.
  • Vir Biotechnology, Inc.
  • Wanbury Ltd.
  • XBiotech Inc.

List of Organizations Mentioned in the Report:

  • Abbreviated New Drug Application (ANDA)
  • CDER (Center for Drug Evaluation and Research)
  • Centers for Disease Control and Prevention (CDC)
  • ClinicalTrials.gov
  • European Commission
  • Food and Drug Administration (FDA)
  • Gates Foundation
  • Government of Japan
  • Korea Centers for Disease Control
  • Minister of Health of the Democratic Republic of the Congo
  • National Development and Reform Commission (NDRC)
  • National Health Service (NHS)
  • National Institute of Health (NIH)
  • National Institute of Statistics and geography (INEGI)
  • NCBI
  • Pan American Health Organization (PAHO)
  • United Nations Programme on HIV/AIDS
  • US Securities and Exchange Commission
  • USFDA (United States Food and Drug Administration)
  • WHO (World Health Organization)
  • World Population Prospects